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SYNOPSIS 
 
The aim of this project was to fabricate a new affinity membrane-based system that is bio-
specific and biocompatible, and which could be used as an adsorption matrix for the 
immobilization of the recombinant protein maltose binding protein human estrogen receptor 
alpha ligand binding domain (MBP-hERLBD).  The viability of the affinity membrane system 
(AMS) for the detection of estrogenic compounds (ECs) in drinking water, using affinity 
principles was determined.  This affinity separation was based on the interaction between the 
analyte 17-estradiol (E2) and the recombinant protein MBP-hERLBD.  The MBP-hERLBD 
was immobilized on a solid matrix support.  The alpha human estrogen hormone receptor 
(hER) was used to test for the binding affinity of the fusion protein to a ligand, radiolabelled E2.  
Each component of this bioaffinity system, from the membrane matrix to the 
expression/purification of the bioligand, and raising of antibodies against the purified bioligand, 
was studied with the aim of producing a well-characterized system with the following 
advantages: robust in nature, cost effective and high loading capacity. 
 
Specifically, this study describes: 
 
1. Expression of the bioligand maltose-binding protein (MBP) to be used as an affinity 
ligand for immobilization onto a solid membrane matrix. 
2. Expression of MBP as a fusion protein to the human estrogen receptor alpha ligand 
binding domain (hERLBD).  
3. The affinity purification of biospecific bioligands (MBP and MBP-hERLBD) using a 
one-step affinity purification system with amylose forming the solid phase of the affinity 
chromatographic column. 
4. Generation of anti MBP-hERLBD antibodies to be used for the characterization of the 
bioligands by means of western blotting. 
5. The fabrication and characterization of a flat-sheet membrane as a model affinity-matrix. 
6. Developing an affinity immobilization protocol for the immobilization of the bioligand 
onto the affinity membrane (AM) matrix. 
7. Quantitative analysis of the immobilized bioligand present on the surface of the 
membrane matrix using tritiated E2. 
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The recombinant protein (MBP-hERLBD) was successfully expressed and purified to form a 
bio-specific ligand for its immobilization onto a cellulose acetate (CA)/amylose functionalized 
affinity membrane.  Polyclonal antibodies were successfully raised against the purified 
recombinant protein.  The anti-MBP-hERLBD antibodies were subsequently used as a potential 
‘marker’ to confirm the immobilization of the recombinant protein onto the CA/amylose 
functionalized membrane.  Attempts to utilize the protein-coated membrane for the selective 
recovery of E2 were, however, unsuccessful.  
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OPSOMMING 
 
Die doel van hierdie projek was om  affiniteits-gebaseerde membraansisteeem te ontwikkel wat 
nie net biospesifiek en bioversoenbaar is nie, maar wat ook as  adsorpsiematriks vir die 
immobilisering van  rekombinante maltose bindingsproteïen menslike estrogeenreseptor-α-
ligand bindingsdomein (MBP-hERLBD) kan dien.  Die lewensvatbaarheid van die 
affiniteitsmembraan sisteem (AMS) vir die deteksie van estrogeen-verwante stowwe (ECs) in 
drinkwater deur die gebruik van affiniteitsmetodes was bepaal.  Affiniteitskeiding was gebaseer 
op die interaksie tussen die analiet 17-estradiol (E2) en die rekombinante proteïen MBP-
hERLBD.  Die rekombinante proteïen, MBP-hERLBD, was op  soliede matriks 
geïmmobiliseer.  Menslike alfa estrogeen hormoon reseptor (hER) was gebruik om vir die 
bindingsaffiniteit van die fusieproteïen aan die ligand, E2 te toets.  Elke komponent van hierdie 
studie, insluitende die bioaffiniteitssisteem, die membraan matriks sowel as die suiwering van 
die rekombinante proteïen en die suiwering daarvan, was bestudeer met  poging tot die 
lewering van  goedgekarakteriseerde sisteem met die volgende voordele: langdurigheid in 
gebruik, koste-effektiwiteit en hoë ladingskapasiteit. 
 
Hierdie studie beskryf spesifiek die volgende 
 
1. Ekspressie van die bioligand, maltose bindingsproteïen (MBP) om as affiniteitsligand te 
dien vir immobilisering tot  soliede matriks. 
2. Ekspressie van  MBP as fusieproteïen tot die menslike estrogeen reseptor-α-ligand- 
bindingsdomein (hERLBD).  
3. Die affiniteitssuiwering van biospesifike bioligande (MBP en MBP-hERLBD) deur 
gebruik te maak van enkel stap affiniteitssuiwering met amilose as soliede fase vir die 
affiniteitschromatografiekolom. 
4. Opwekking van anti-MBP-hERLBD-antiliggame wat gebruik kan word vir 
karakterisering van bioligande met behulp van Imunnokladtegnieke 
5. Die ontwikkeling en karakterisering van  platvelmembraan as  model vir 
affiniteitschromatografie. 
6. Die ontwikkeling van  affiniteitsimmobiliseringsprotokol vir die immobilisering van die 
bioligand op  affiniteitsmembraanmatriks. 
7. Kwantitatiewe analisering van die geïmmobiliseerde bioligand teenwoordig op die 
oppervlak van die membraanmatriks deur gebruik te maak van 17-estradiol. 
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Die rekombinante proteïen (MBP-hERLBD) is suksesvol uitgedruk en gesuiwer om  
biospesifieke ligand vir die immobilisering daarvan op selluloseasetaat (CA)-amilose 
funksionele affiniteitsmembraan.  Poliklonale teenliggame, gerig teen die gesuiwerde 
rekombinante proteïen, is suksesvol opgewek.  Die anti-MBP-hERLBD-antiliggame is 
vervolgens as  potentiële merker geïdentifiseer om die immobilisering van die rekombinante 
proteïen op die CA-amilosemembraan te bevestig.  Pogings om die proteïenbedekte membraan 
vir die selektiewe herwining van E2 te gebruik was onsuksesvol.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 BACKGROUND TO PRESENT STUDY 
 
There is growing evidence that certain hormone active agents in the environment can disrupt 
chemical messengers (hormones) of the endocrine system by sending erroneous signals or 
blocking legitimate signals.  The putative hormone active agents, also known as endocrine 
disrupting compounds (EDCs), exert their profound and deleterious effects on humans and 
wildlife by mimicking, blocking and disrupting the physiological functions of the messengers of 
the endocrine system [1,2].  These chemical messengers generally exert their functions by 
interacting with their corresponding receptors in the cells to trigger responses and prompt normal 
biological functions such as growth, development, behaviour and reproduction [2].  Interferences 
with the activities of the chemical messengers, such as is the case with EDCs, will damage the 
system receiving the message.  These interferences can lead to reversible or irreversible 
abnormal biological outcomes including stunted growth, impairment of short term memory, tubal 
pregnancy, low sperm count, reproductive failure and damage of the immune system [1,2].  It is 
clear that as researchers continue to look at the adverse effects caused by these hazardous 
compounds on humans and wildlife they continue to find significant, often permanent, effects at 
remarkably low doses. 
 
EDCs can be categorized into three major groups according to the abnormal biological 
conditions they exert on humans and wildlife.  The three major groups include: androgenic 
(compounds that mimic or block natural testosterone), thyroidal (compounds with a direct or 
indirect impact on the thyroid glands) and estrogenic (compounds that mimic or block natural 
estrogens).  Despite the broad spectrum of EDCs, it is the estrogenic compounds (ECs) that are 
the most prominent and most studied [3].  This is in all likelihood due to the importance of ECs 
in cancer research [2].  ECs are found in low doses in literally thousands of products, some of 
which include: diethylstilbestrol, bisphenol A, polybrominated diphenyl ethers and phthalates.  
These compounds have been widely reported to be present in very low concentrations in the 
environment, but their relatively high fat solubility enables them to bioaccumulate up the food 
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chain, leading to significant physiological responses at these low concentrations [2].  Other 
relevant sources of endocrine disrupting chemicals are found in insecticides, herbicides, 
fungicides, plasticizers, plastics, resins and industrial chemicals such as detergents.  The 
hydrophobicity of ECs, coupled with other chemical properties, has created unique challenges to 
environmental analytical chemists in developing techniques required for detecting and screening 
of these compounds.  Several analytical techniques have been used to detect these compounds in 
the environment [2,3-5].  Analytical methods frequently used for detecting these compounds 
include: high performance liquid chromatography (HPLC) [6,7], liquid chromatography/mass 
spectrometer (LC/MS) [8,9], gas chromatography/mass spectrometer (GC/MS) [10,11], and solid 
phase extraction (SPE) [12,13].  These techniques are, however, generally unsuitable for large 
scale detection.  Their use is further limited due to costs, intensive labour and the relatively poor 
sensitivity of the techniques, since they are specific only for one analyte or a limited class of 
structurally related compounds.  However, affinity chromatography (AC) is considered to be an 
effective method for analytical detection of ECs in the environment [14]. 
 
AC systems are powerful techniques in which biospecific and reversible interactions are used for 
the selective separation and purification of biological molecules from complex biological 
matrices [15-17].  These systems are increasingly being used in the field of biotechnology due to 
the specific interaction between the immobilized ligands (usually grafted or linked to the matrix 
via the use of a spacer arm) and the bio molecules to be separated.  These affinity systems 
consist of two distinct parts: the mobile phase, which carries the biological molecule to be 
separated and the solid phase, which is usually modified to carry the affinity ligands.  Not 
withstanding the fact that these systems are widely used, they still have some shortcomings, 
including the requirements for a large column set-up and a longer diffusion path length, which in 
turn leads to a significant increase in the time required for the entire downstream processing 
from the introduction of the crude extract to the final purified product.  Membrane affinity 
chromatography (MAC) was introduced to overcome some of the shortcomings of column 
affinity chromatography.  Its introduction has significantly reduced the number of steps needed 
to obtain a pure product due to the specificity of the interaction between the stationary phase and 
the target biomolecule, not withholding the larger surface area and shorter diffusion path length 
that the system offers [18].  With the above-mentioned advantages, affinity membrane system 
(AMS) should serve as a powerful technique for analytical detection and removal processes of 
ECs from the environment. 
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ECs mimic or block the endogenous estrogens by binding to the ligand binding domain of the 
estrogen receptors (ERs) of the endocrine system.  Exploiting the interaction existing between 
the estrogen and its receptors, and using the chemical information obtained from this interaction, 
a more reliable and more specific analytical method (i.e. a composite CA/amylose functionalized 
affinity membrane) than the HPLC, GC, MS and LCMS techniques can be introduced for 
detecting and concentrating ECs in the environment. 
 
1.2 OBJECTIVES 
 
This project aims at proving that synthetic CA/amylose functionalized AM can be used as 
affinity adsorption matrices for the immobilization of recombinant protein (MBP-hERLBD).  
The AMS could be used to design other models that will provide a means of capturing molecules 
such as large proteins, antibodies, enzymes and other biological molecules from their respective 
environments.  Each component of this bioaffinity system, starting from the membrane matrix to 
the expression/purification of the recombinant protein, the generation of antibodies against the 
purified protein, and the immobilization of the protein on the membrane is to be studied with the 
aim of producing a well characterized AMS with the following advantages: robustness, cost 
effectiveness and regeneration properties. 
 
The objectives of this study can be classified into two main groups; 
 
1.  The fabrication of a composite CA/amylose functionalized affinity membrane for the 
immobilization of the affinity ligand (MBP-hERLBD). 
2. Application of the MBP-hERLBD-immobilized hybrid membrane for the selective 
recovery of specific biomolecules, in this case ECs. 
 
1.3 METHODOLOGY 
 
The affinity membrane process developed in this project will involve the immobilization of the 
carrier MBP-hERLBD fusion protein onto a CA/amylose hybrid membrane.  This hybrid 
membrane will be designed to increase the stability of the carrier.  The MBP, with its affinity for 
amylose, will interact specifically with the amylose in the composite affinity membrane while 
the hERLBD on the other hand will be used as a potential receptor to capture the ECs present in 
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the solution. 
 
Concisely, in order to achieve the above-mentioned objectives, the experimental rationale and 
attendant tasks are briefly described below, and a simplified flow diagram illustrating these 
experimental tasks is depicted in Figure 1.1. 
 
1.3.1 Expression of MBP-hERLBD 
 
The pMalc2 vector, containing the cloned gene (hERLBD), was transformed into a TB1cell 
expression system.  MBP-hERLBD expression was induced by the addition of isopropyl--D-
thiogalactopyranoside (IPTG) in the growth solution.  After sonication of the cell suspension, the 
protein was harvested by centrifugation. 
 
1.3.2 Purification of MBP-hERLBD 
 
Purification of the expressed proteins (MBP-hERLBD) was achieved following the basic 
principles of conventional affinity chromatography on an amylose resin.  
 
1.3.3 Antibody generation  
 
The purified MBP-hERLBD was used to elicit polyclonal antibodies in rabbits.  Serum from 
the rabbit was collected on days 0, 28, 43 and 45 for the determination of the antibody titre.  The 
antibodies was used to asses the ability of the new hybrid membrane to immobilise the expressed 
MBP and MBP-hERLBD. 
 
1.3.4 Membrane fabrication and characterization 
 
Membranes were fabricated from commercially available polymers, CA and amylose, using the 
immersion precipitation technique.  Sections of the fabricated membrane (1cm2) were used as 
matrices for membrane surface characterization by scanning electron microscopy (SEM), and 
Fourier transform infrared spectroscopy (FT-IR). 
 
1.3.5 Protein immobilization 
 
Sections of the manufactured hybrid membranes (1cm2) were used for the immobilization 
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procedures.  This was achieved by incubating the 1cm2 membranes in a solution containing the 
recombinant protein (MBP-hERLBD). 
 
1.3.6 Immobilized membrane quantification 
 
Following the immobilization of the recombinant protein onto the hybrid membrane, the 
immobilised hERLBD was used for capturing radio labelled 17-estradiol (E2) in 
environmental solution.  The efficiency of E2 captured by the membrane-immobilised hERLBD 
was assessed by liquid scintillation spectrometery. 
 
 
Figure 1.1: Flow diagram illustrating the methodology used in this study. 
 
 
Expression of MBP from pMAlc2  
(Control) 
Affinity purification of the expressed biospecific ligands (MBP 
and MBP-ERLBD) for 
Immunization of a rabbit for possible antibody production against 
the purified biospecific ligands 
Affinity membrane matrix fabrication and characterization 
Immobilization of MBP onto the 
affinity matrix 
Immobilization of MBP-ERLBD 
onto the affinity matrix 
 
Qualitative assay (Western blot 
analysis) for positive confirmation of 
the immobilized biospecific ligands 
Affinity interaction between the MBP-
ERLBD and E2 
Quantitative (radioactive) assay for 
positive confirmation of membrane 
recovery capacity 
Expression of MBP-ERLBD from 
pMAlc2  
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1.4 LAYOUT OF THESIS 
 
A brief description of the aims and significance of each chapter of this thesis is outlined below. 
 
In Chapter 1, a brief background on EDCs is presented.  The concept of membrane affinity 
separation as an application process in biotechnology is also discussed.  The objectives of the 
study within the confines of the broader aim of developing a reliable affinity membrane for 
protein biomolecule separation coupled with a concise lay out of the thesis are presented. 
 
A literature review of the field of liquid chromatography and membrane technology is presented 
in Chapter 2.  Herein, different types of liquid chromatography systems are discussed, with 
emphasis on affinity chromatographic systems.  Membrane configuration, models/designs and 
membrane transport mechanism are also discussed.  The structural/functional characteristics of 
MBP and an overview on EDCs are presented. 
 
The expression and purification of MBP and the recombinant MBP-hERLBD fusion proteins 
are discussed in Chapter 3.  The pMalC2 expression vectors harbouring the proteins of interest 
were used for expression in a TB1 cell expression host system.  Soluble products obtained from 
the expression were purified using a one-step purification system.  
 
Immulogical studies on MBP-hERLBD are described in Chapter 4.  This chapter deals with the 
preparation of antibodies against the purified MBP-hERLBD and the application of these 
antibodies for the specific detection of MBP and MBP-hERLBD fusion proteins. 
 
The fabrication of a functionalized composite flat-sheet membrane using the immersion 
precipitation method is described in Chapter 5.  Membrane characterization using SEM and FT-
IR are also discussed in the same chapter.  Qualitative and quantitative analyses were performed 
on the fabricated membranes, and the results obtained are documented in Chapter 6. 
 
In Chapter 7, the findings obtained from this experimental work are summarised. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
The selective recovery, purification and characterization of biomolecules is a very important 
phenomenon in biotechnology.  The high demands for ultra-high purity and yield of these 
biomolecules coupled with the rapid progress made and achievements attained in the fields of 
medical and biopharmaceutical applications have led to the development of methods for 
generating large sets of genomic and proteomic biomolecules.  Some of these biomolecules (e.g. 
DNA, interferons, vaccines, antibodies, therapeutic proteins, polypeptides, hormones, 
polynucleotides, insulin, erythro proteins, tissue plasminogen activator [1,2]) are extremely 
sensitive  and recovery of these molecules from their biological host environment requires great 
attention to their unique characteristics [3]. 
 
Some industries and commercial sectors are known for producing and discharging large 
quantities of heavy metals into the environment [4].  These heavy metals include nickel, lead, 
mercury, silver, selenium, zinc, copper, arsenic and cadmium, all of which are known to pose a 
great threat to human health when released in any quantities into the environment.  As previously 
mentioned in Section 1.1, several endocrine modifying chemicals are constantly being released 
into the environment [5,9].  These environmental endocrine disruptors (EED) are usually 
byproducts of industrial wastes or from agricultural run-offs.  EED are a broad group of 
compounds known to interfere with the normal functioning of the endocrine system, leading to 
abnormal biological conditions in humans and wildlife.  Creating a downstream process for the 
selective recovery of these metals/chemicals from the environment as soon as they are 
discharged is therefore very important. 
 
Considering the increasing need for biomolecules by pharmaceutical companies, coupled with 
the large number of hazardous chemicals constantly released into the surroundings, there is an 
increasing need for methods that will facilitate rapid, reliable and efficient screening and 
recovery of these biomolecules and chemicals.  Various downstream separation techniques have 
been used in the field of biomolecules separation [10-15], amongst which column 
chromatography has been the most successful.  Within the frame of liquid column 
chromatography, affinity column chromatography has exhibited the best performance in terms of 
product purity with respect to its high specificity [16-21].  However, due to the high costs and 
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tedious input required associated with conventional column chromatography, researchers’ efforts 
have shifted towards the use of membranes as affinity matrices for high-resolution separation of 
biomolecules.  An example of such a matrix has been illustrated with bioreactors [22,23] in 
which the membrane processes have shown greater scope than conventional support matrices 
such as polymeric beads and agarose gel [24,25]. 
 
2.2 CHROMATOGRAPHY 
 
Among the many techniques used in biotechnology for product recovery purposes over the past 
few decades, chromatography has been the most successful.  The term chromatography was first 
coined by Tswett in 1906 where he referred to chromatography as any separation technique 
involving components distributed between a stationary and a mobile phase.  Separation of a 
sample is necessitated by the fact that the sample components have different affinities for both 
the stationary and mobile phases, and therefore the compounds migrate at different rates along 
the column.  Chromatographic separations can be carried out using a variety of supports, 
including immobilized silica on glass plates (thin layer chromatography), volatile gases (gas 
chromatography), paper (paper chromatography), and liquids, which may incorporate 
hydrophilic, insoluble molecules (liquid chromatography).1  Liquid chromatography has been the 
most widely used chromatographic technique due to its high selectivity and purity of the 
resulting biomolecules. 
 
2.3 LIQUID CHROMATOGRAPHY 
 
Some examples of liquid chromatographic techniques are briefly described below. 
 
2.3.1 Ion-exchange chromatography 
 
The use of Ion-exchange chromatography (IEC) allows molecules to be separated based upon 
their charge.  Families of molecules (acidic, basic and neutral) can be separated by this 
technique.  Basic proteins, which are positively charged, will bind to a support, which is 
negatively charged, while acidic proteins, which are negatively charged, will bind to a positive 
support.  Elution of the desired product is usually accomplished by simply increasing the salt 
concentration or altering the pH of the eluting buffer. 
                                                    
1
 Wilson, K. (2005). In Chromatographic techniques. Wilson, K & Walker, J., Principles and Techniques of 
Biochemistry and Molecular Biology, 6th edn. 40 west 20th street New York, (485-550) USA. 
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2.3.2 Hydrophobic interaction/Reverse phase chromatography 
 
Generally, not all molecules to be separated are charged molecules.  Some molecules contain 
hydrogen side-chains that are not charged and therefore cannot be separated using the ion-
exchange technique.  These hydrophobic molecules contain their active groups (e.g. amino acids) 
buried inside the molecule as the molecule folds to its native form.  During hydrophobic 
interaction, these hydrophobic molecules will bind to a support that contains immobilized 
hydrophobic groups.  The interaction taking place between the hydrophobic molecules and the 
immobilized hydrophobic support is the “clustering” effect, since no covalent and ionic 
interactions are involved.  Elution of the desired product from the hydrophobic adsorbents can be 
effected by lowering the temperature, change in pH, or by adding a polyol such as ethylene 
glycol or a non ionic detergent to the elution buffer [3]. 
 
2.3.3 Gel-filtration chromatography 
 
Gel-filtration chromatography (GFC) also known as size-exclusion chromatography is an 
isocratic system, based on the ability of molecules to move through the column of gel that has 
pores of clearly defined sizes.  The larger molecules cannot pass through the pores, thus they 
pass quickly through the column and elute first.  The slightly smaller molecules can enter some 
pores and so take longer to elute.  The smallest molecules will go through most or all the pores 
and will thus be delayed longer in the column.  
 
2.3.4 Affinity chromatography 
 
The term affinity chromatography (AC) was first used in 1968 by Cuatrecasas et al. [26].  It is a 
type of adsorption chromatography in which the molecule to be separated is specifically and 
reversibly adsorbed by a complementary bio-specific ligand that is covalently attached to the 
chromatographic bed material or the matrix [16].  The complexes formed as a result of the 
interactions taking place in the process are often similar to complexes occurring in nature.  The 
molecular forces and bond interactions forming these complexes are systematic, and include 
ionic bonds, hydrophobic interactions, hydrogen bonding, Van der Waals forces, London 
dispersive forces, dipole-dipole interactions and charge-transfer interactions [16]. 
 
Each of the above-mentioned separation techniques is based on a particular property of the 
biomolecules to be separated, i.e. how these biomolecules differ from one another and also the 
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interaction existing between the molecule and the stationary phase of the column.  Some of the 
properties that are used as basis for separation are: 
 
• charge; 
• hydrophobicity; 
• affinity (biological affinity for another molecule); 
• solubility or stability (sensitivity to the effects of environmental conditions, such as heat); 
and 
• molecular mass. 
 
Among the above-described chromatographic techniques, AC occupies a unique place in 
separation technology since it is the only technique that enables the separation of almost any 
biomolecule on the basis of its biological or chemical structure.  Comparisons between the 
different types of liquid column chromatographic techniques are listed in Table 2.1. 
 
Table 2.1: Comparisons between different types of liquid column chromatographic techniques 
[27] 
Property Affinity  Ion-exchange Reverse phase/ 
hydrophobic 
 Group specific Bio-specific  interaction 
Adsorption capacity Medium-high Low High Medium-high 
Selectivity Medium-high High Low-medium Low-medium 
Recovery High Medium High Medium 
Loading phase Mild Mild Mild Usually harsh 
Elution phase Mild Harsh Mild Mild 
Regeneration Complete Incomplete Complete Incomplete 
Cost Low High Low Low 
 
The understanding and quantification of the interactions taking place within the solid-liquid 
interface during AC have recently become important areas of study since the introduction of 
highly sensitive and non-destructive analytical techniques such as, scanning probe microscopy, 
ellipsometry and surface plasmon resonance spectroscopy [28]. 
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2.4 SALIENT CHARACTERISTICS OF AFFINITY MATRICES 
 
When designing an affinity chromatographic system, the solid support should be the first, and 
most important point of consideration, since it comprises the greater part of the column and it is 
also the domain onto which the biomolecules couple.  Designing such a domain must be 
carefully done to favour the interaction between the support and the molecule of interest.  
Affinity matrices are usually designed to make use of the physical and chemical properties of the 
molecule of interest.  In designing such a matrix, certain salient characteristics need to be taken 
into consideration [27, 29]: 
 
• it must be insoluble in the buffers used; 
• it must possess good flow characteristics; 
• it must have mechanical and chemical stability; and 
• it must have sufficient surface area available for ligand accessibility. 
 
Generally, AC matrices are usually classified into two groups: first, the predominantly single-
composition matrices (e.g. agarose, collagen, cellulose, and controlled pore glass), and second, 
the dual composition and/or chemically modified matrices (e.g. agarose coated polyacrylamide, 
cross-linked agarose and acrylic coated iron particles [30]).  One of the most widely used 
matrices is the sepharose beads.  This bead-formed agarose gel displays virtually all the features 
required of a successful matrix for the immobilization of biologically active molecules.  The 
sepharose beads contain hydroxyl groups that can be easily derivatized for covalent attachment 
of the ligand. 
 
2.4.1 Ligands for affinity chromatography 
 
As previously mentioned, AC involves the immobilization of bio-specific ligands (biological and 
synthetic) onto a solid support [31].  The correct choice of a ligand complementary to the 
biomolecule to be separated still poses one of the most challenging problems in the use of this 
separation technique [32].  Selecting a biological ligand for an affinity chromatographic system 
is thus influenced by two major factors.  First, the bio-ligand to be immobilized should exhibit 
specific and reversible binding affinity for the substance to be purified and, second, it should 
have chemically modifiable groups that allow it to be attached to the solid support (matrix) 
without destroying the binding activity of the ligand.  Selecting synthetic ligands for AC can be 
categorized into three main groups: rational, combinatorial and the combined [33].  A brief 
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comparison between the biological and synthetic ligands used in AC systems is presented in 
Table 2.2 below. 
 
Table 2.2: Comparisons between biological and synthetic ligands [33] 
 
Ligand 
category 
Factors under  consideration    
 Selectivity Stability Capacity Cost Toxicity 
Synthetic Medium to 
high 
High High Low to medium Medium 
Biological Very high Low to medium Low to 
medium 
Medium to high Low 
 
During binding of the bio-ligand to the solid support, it is important to take into consideration 
which region of the ligand interacts with the support.  If the ligand contains several coupling 
groups, the group with the least binding affinity for the biomolecule to be separated should be 
used in forming the complex with the solid support.  Some commonly used ligands or ligates 
used in AC include amino acids, dye ligands, metal chelating ligands, ion-exchange ligands, 
immunoaffinity (antibodies and antigens) ligands. 
 
The development of recombinant protein technology [33] and the use of pseudobiospecific 
ligands (e.g. reactive dyes, metal ions, L-histidine) [34] has been very useful in solving some of 
the problems regarding ligand choice in AC.  Several epitope peptides and proteins have been 
developed recently to over-produce recombinant proteins [35]. 
 
Despite the enormous efforts invested in the field of AC, a few aspects regarding the AC system 
remain unresolved.  These include insufficient ligand binding capacity of the support, lack of 
bio-specificity of the affinity ligand, different coupling methods, high pressure packing, pressure 
drop in the column, slow intra-bead diffusion of solutes, physical and chemical stability of the 
system, and the cost involved [36, 37].  These shortcomings of the system have prompted 
researchers to develop affinity membranes or modify traditional membranes to affinity matrices 
as alternative AC matrices [1,3]. 
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2.5 MEMBRANE DEVELOPMENT 
 
2.5.1 Introduction 
 
Membrane filtration systems are finding an increasing number of applications worldwide, in the 
purification of potable and industrial water, water desalination, as well as in the removal of 
heavy metal ions, nitrates, phosphates, pesticides and phenol [38,39].  These membrane systems 
are not only used in water reclamation, but have also resulted in numerous applications in fields 
of pharmaceutical and biomedical applications [40].  Their design and use is set to grow 
considerably in years to come due to their importance in these applications.  With the recent 
development of membrane technology, new knowledge has been applied for the production of 
more complicated and efficient synthetic membranes with the ability to compartmentalize 
processes.  Membrane filtration systems are currently the best available technology for water and 
wastewater treatment [41-44]. 
 
The extensive use of such membrane filtration systems has led to the development of different 
types of membranes filters (hollow fibre and flat sheet forms), classified according to the size of 
the particles that can pass through the membrane pores.  In descending order, by pore size, the 
different types of membrane technology include: microfiltration (MF), which removes particles 
down to 0.1 microns; ultrafiltration (UF), which removes particles from 0.01 to 0.1 microns; 
nanofiltration (NF), which removes most organic compounds; and reverse osmosis (RO), which 
removes dissolved salts and metal ions [41,43,44]. 
 
Subsequent to the recent advances in membrane material technology, various membrane 
separation processes have been investigated as alternative techniques to solid phase extraction 
(SPE) [10-15].  Among these, applications of liquid membrane processes in the separation of 
metal ions have been extensively studied [38,39].  Although these membrane processes have 
shown feasibility to some extent, they have not attained large-scale commercial application, most 
probably because of the membrane instability, loss of organic solvents, expensive clean-ups, 
poor robustness and difficulty with regeneration of the organic carriers.  In consideration of these 
shortcomings, a new technique for solvent extraction with an immobilized interface was raised, 
originally by Kiani et al. [45].  Although this technique did reduce the aspect of instability to 
some extent, the loss of organic carriers still persisted.  
Stellenbosch University http://scholar.sun.ac.za
 16 
Application of a membrane for the adsorptive recovery of biomolecules can be categorized 
according to the ligand chemistry of adsorption [3].  Membranes can also be used as an affinity, 
ion-exchange, hydrophobic and reverse-phase matrix for biomolecular separation. 
 
2.5.2 Affinity membrane separation 
 
The first membrane chromatographic system, developed in 1988, was introduced to resolve most 
of the shortcomings experienced by the existing traditional column chromatographic techniques 
[46].  Membrane chromatographic systems operate in convective mode, which can significantly 
reduce the diffusion limitation commonly encountered in column chromatography [1].  A recent 
variation of membrane filtration, membrane affinity chromatography (MAC), was introduced to 
increase the sensitivity of membranes towards targeted biomolecules [47].  MAC, just like the 
conventional affinity chromatography, exploits the molecular recognition between an 
immobilized ligand and the target molecule.  In the MAC system the ligands routinely used are 
the pseudo-specific ligands2 (e.g. dyes, amino acids, chelated metal ions) rather than biospecific 
ligands such as proteins, antibodies, bacterial proteins, receptors and lectins used in the earlier 
systems [34].  The use of pseudo-specific ligands in the MAC system is most probably 
encouraged by the inherent instability of the biospecific ligands during the cleaning-in-place and 
the sanitary-in-place procedures applied in cleaning the membrane system.  The absorption of 
biospecific ligands to solid supports is a very complex process.  It is determined by the chemical 
structure, surface roughness, the degree of hydrophobicity of the surface, the electrostatic 
interactions of the biospecific molecules with each other and with the surface and the structural 
stability of the biospecific ligand.  Most biospecific molecules, when immobilized to a polymer 
membrane, undergo a conformational change that can greatly affect the integrity of the ligand 
[48]. 
 
The membrane chromatography systems have proven to be generally superior to the 
conventional affinity chromatography in certain aspects; in the case of the former system there is 
a convective flow of the solute through the membrane, no intra-bead diffusion (Figure 2.1) and 
small thickness of the membrane can result in a low or negligible pressure drop, which in turn 
causes a high flow-rate within the system.  The membrane system experiences no bed 
compaction and can be scaled up easily.  Additionally, in order to serve as affinity adsorbents, 
                                                    
2
 Ligands that have a structural similarity to the natural ligand of an enzyme or a receptor. 
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these membranes can be designed or modified as ion-exchange, hydrophobic interaction and 
filtration membranes.  Herein, the interaction between the dissolved molecules and the active 
sites on the membrane occurs by convective flow through the pore, rather than in the stagnant 
fluid inside the pores of an adsorbent matrix [49]. 
 
 
Packed bed chromatography
Membrane chromatography
Bulk convection
Bulk convection
Film diffusion
Film diffusion
Pore diffusion
 
Figure 2.1: Solute transport in packed bed chromatography and membrane chromatography [50]. 
 
Although the membrane chromatography system presents a greater advantage to the packed bed 
column, the large diameter to length ratio of the membrane introduces the challenge of achieving 
uniform flow distribution across the membrane.  Yuan et al. [51] designed a membrane system to 
overcome this problem.  This membrane system gave a uniform distribution in numerical 
simulation and laboratory prototypes. 
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2.5.3 Membrane configuration and module designs 
 
Membrane systems are usually designed to allow the continuous free flow of solution within the 
system [3].  The different module designs result in different flow-operation conditions and 
distinct separation efficiencies.  Various membrane shapes and module designs have been 
developed taking into consideration the different adsorptive membrane processes.  The 
membrane systems were derived from filtration modules and thus exist in a variety of 
configurations (i.e. stacked membranes, hollow fibre membranes, spiral-wound membranes, 
plate-and frame membranes) [3].  The two most commonly used shapes of membranes in 
appropriate module designs are the flat-sheet and the hollow-fiber membranes [1], of which the 
former have been most widely used [50].  Typical modules used in membrane housing and 
commonly used membrane configurations are illustrated in Figures 2.2 and 2.3 respectively. 
 
 
 
Disc holder Plate and frame module Spiral-wound 
cartridge
Hollow fiber 
cartridge
permeate
retentate inlet
 
 
Figure 2.2: Schematic diagrams for some typical membrane modules [1]. 
 
The different module designs operate at different flow rates.  The appropriate design of a 
membrane chromatography module is only possible when the transport phenomena involved are 
well understood.  Detailed literature regarding the membrane shapes, modules, and transport 
phenomena of membrane chromatography has been documented [1,50]. 
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2.5.4 Transport phenomena in membrane chromatography 
 
The predominance of convective material transport has given membrane chromatography a great 
advantage over the packed-bed system.  In membrane chromatography, the dissolved solute 
molecules are transported through an adsorptive membrane by bulk flow of the mobile phase.  
Within the system, the bulk flow of solvent carries the solute molecules toward the outlet at the 
same rate in which the solvent flows in the chromatographic system.  During the transport of the 
adsorbate molecules the ideal equilibrium separation is affected by three main factors: Brownian 
thermal diffusion, dispersion and kinetic sorbate-sorbent interaction [3].  Much work has been 
done on the transport phenomena of membrane chromatography, as documented in several 
research papers [3,52-58].  Figure 2.4 shows a schematic representation of solvent movement in 
membrane adsorbers [50]. 
 
Figure 2.3: Schematic diagrams for commonly used membrane configurations, with 
arrows illustrating the directions of bulk flow [3]. 
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2.5.5 Matrices used in adsorptive membranes 
 
In designing a system for affinity membrane separation, the first point to take into consideration 
should be the composition of the membrane matrix.  The matrix design should take into account 
the biomolecules to be separated as well as the solvent required for its separation.  An ideal 
matrix should have similar characteristics as conventional chromatographic matrices [3,59,60].  
The required matrix characteristics include: 
 
• high hydrophobicity and low non-specific adsorption; 
• high specific surface area; 
• fairly large pore sizes; 
• high chemical, thermal, and mechanical stability; and 
• sufficient surface functional groups. 
 
In general, matrix materials can be categorized into two main groups: polymeric and inorganic 
materials [1,3].  The latter usually show better performance in terms of mechanical strength, 
thermal stability and chemical resistance than the former.  On the other hand, the pore properties, 
Figure 2.4: Schematic representation of flow in membrane adsorbers [50]. 
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cost, and capability for surface modification of the polymeric matrices are more competitive [1].  
Some commonly used materials for matrices’ fabrication include titanium, silicon dioxide glass, 
cellulose, regenerated cellulose, nylon, poly(glycidyl methacrylate-co-ethylene dimethacrylate), 
poly(glycidyl methacrylate), polyethylene, poly(styrene-co-divinylbenzene), polyvinylalcohol, 
polysulfone, polyethersulfone and polycarbonate [3].  The properties of these materials have 
been thoroughly evaluated in several review papers [61-71]. 
 
2.5.6 Selection of ligands for adsorptive immobilization 
 
The ligand type in adsorptive membrane chromatography is generally used to categorize the 
affinity mode.  The following selected criteria should be taken into account when choosing a 
ligand: 
 
•  the ligand must specifically and reversibly bind the targeted molecule and must 
contain groups that can be chemically modified to allow attachment to the 
support; and 
• the chemical modification of the ligand must not impair its specific binding 
activity [72]. 
 
Ligands are commonly classified into two main groups, namely general or group specific 
ligands, such as metal ions, affinity dyes, amino acids, proteins A and G, lectin and coenzymes, 
and specific or bio-specific ligands, such as enzymes and substrates, antibodies and antigens.  
Although the bio-specific ligands have proven to offer a better selectivity than pseudo-specific 
ligands, the pseudo-specific or group specific ligands have gained increasing attention in the 
field of adsorptive membrane chromatography [1].  The various types of ligands used in affinity 
chromatographic systems and their corresponding ligates are summarized in Table 2.3. 
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Table 2.3: Ligands used in affinity chromatographic systems and their corresponding ligates [73] 
 
Ligands  Ligates 
Cibacron Blue 
F3GA 
 Enzymes, calmodulin, serum albumin, lipoprotein, 
interferon, thrombin, synthetase, transferase, 
myogubin, growth factor  
Dyes Protein Red 
HE3B 
K2BP 
Enzyme, lipoprotein, cytotoxicity, carboxypeptidase 
G, kinase, dehydrogenase, alkaline phosphatase, 
polypeptide hormone 
Amino Acid Trp 
Arg 
Lys 
His 
Phe 
Carboxypeptidase A 
Serine proteinase 
DNA, RNA 
Pyrogen, endotoxin, yeast proteinase 
-Glubulin 
Protein A and G Concanavalin A 
Lentil lectin 
IgA, IgG, IgM, antibody, insulin-like growth factor 
Polysaccharide, glycoproteins, membrane 
glycoproteins, glucolipid, enzymes and coenzymes 
with glycosyl 
Lectin Wheat germ 
lectin 
Peanut lectin 
 
Heparin  Human antithrombin polymerase, coagulation factor 
Polymyxin B  Endotoxin 
Metal chelates  Histidine, tryptophan, cysteine-containing proteins 
Gelatin  Fibronectin 
Calmodulin  Phosphodiesterase, ATPase, and calcinerin 
Benzamidine  Urokinase, trypsin, thrombin, kallikrein 
Hormone  Receptor 
DNA, RNA, ribose  Nuclease, polymerase, nucleotide 
Antibody  Antigen 
Antigen  Antibody 
Enzyme  Enzyme inhibitor 
Enzyme inhibitor  Enzyme 
Enzyme cofactor  Enzyme 
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Although MAC has several distinct advantages over conventional chromatography, the MAC 
system does have some shortcomings, for example: 
• inlet flow distribution; 
• low binding capacity between the ligand and the solid support; 
• uneven membrane thickness; and 
• pore distribution on the membrane [3] 
 
Following the short-comings faced by the MAC system, as earlier mentioned in Section 1.3, a 
new membrane affinity system will be established to combat some of the drawbacks.  Briefly, 
the affinity ligand (hERLBD), used for the selective separation of the targeted biomolecule, 
will be expressed as a fusion protein to MBP.  The resulting recombinant protein will, through 
affinity interaction, bind to a domain (amylose) that forms an integral part of the membrane 
matrix. 
 
2.6 THE MALTOSE BINDING PROTEIN 
 
2.6.1 Introduction 
 
The malE gene that codes for MBP is part of the maltose/maltodextrin transport system of the E. 
coli.  This transport system is responsible for the uptake and efficient catabolism of maltose and 
its higher homolog, maltodextrin [74].  It is a complex regulatory and transport system involving 
many proteins and protein complexes.  The MBP is a soluble protein located in the periplasm of 
the E. coli [75].  In collaboration with an inner membrane-associated protein complex forming a 
channel (MalFGK2), the MBP, through affinity interaction, actively transports the saccharides 
maltose and its higher homologs across the cytoplasmic membrane of the E. coli.  The MBP and 
the inner membrane-associated complex both constitute the maltose transport specific system, 
which belongs to the large family of the ATP binding cassette, the ABC transporter [76,77].  
Also, in association with the membrane chemotransducer, the MBP are involved in the 
chemotactic response of E. coli to maltose [78-80].  It should, however, be noted that the protein-
dependent transport system not only recognises and tightly binds not only the disaccharide 
maltose, or the long linear maltodextrin but it is also involved in the transportation of even 
cyclodextrins with Kd value in the micromolar range [81].  The transportation of the maltose and 
its homologs across the cytoplasmic membrane is facilitated by the unique structure of the MBP. 
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2.6.2 Structure of the MBP 
 
The MBP is the second largest binding protein in the family of binding proteins located in the 
periplasm of the gram-negative bacteria (E. coli).  The periplasmic located protein, as reported 
by X-ray crystallography, is a protein with a relative molecular mass of approximately 40.6 kD 
and comprising 370 amino acids [82].  MBP is structurally composed of two main domains of 
approximately equal sizes, with the domains separated from each other by a deep groove (the 
ligand binding site) [83].  Each of the two domains is built from a secondary structural element 
belonging to both the amino- and carboxyl-terminal halves of the protein [82]. 
 
The ligand binding site, located in the deep groove separating the two domains is, heavily 
populated by polar and aromatic groups, some of which interact with the maltose and its higher 
homologs through hydrogen binding and van der Waals interactions.  Upon binding of the ligand 
to the binding cleft, the MBP undergoes a conformational change from the open to the closed 
conformation, completely preventing the ligand from being accessed by the environmental 
solvent [83]. 
 
    
Figure 2.5: Graphic illustration showing the ribbon-style drawing of MBP [83]. 
 
The three-dimensional structure of the MBP as illustrated in Figure 2.5 shows the characteristic 
alpha and beta conformations of the two globular domains joined by the hinged region.  The 
binding site for maltose and the maltodextrin is located in the deep groove found between the N 
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and the C domains.  The beta strands and alpha helices are represented as flat arrows and coils 
respectively. 
 
2.6.3 Translocation of MBP across the cytoplasmic membrane 
 
In the periplasm of E. coli MBP serves as a soluble receptor for the high affinity transportation 
of maltose and maltodextrin [77].  The MBP or MalE of E. coli, just like other proteins of the 
eukaryotic cells [84-88], is synthesized in the cytoplasm as a precursor protein, preMalE [89].  
Once the precursor protein is synthesized it is transported across the cytoplasmic membrane into 
the periplasm of the organism [90].  The translocation of the precursor molecule across the 
cytoplasmic membrane is initiated by an extension of some 15 to 30 predominantly nonpolar and 
hydrophobic amino acids [89].  The amino acid extension (the signal sequence) is generally 
heterogeneous in primary sequence and, as observed [91], many of the amino acid sequences can 
substitute for a natural signal sequence, at least partially.  Therefore, signal sequence function 
does not appear to require a specific sequence of amino acids to initiate the translocation process.  
Once the translocation of the precursor protein across the cytoplasmic membrane is completed, 
the signal sequence is cleaved by the signal peptidase and the mature protein is released from the 
membrane into the periplasm where it folds to its native conformation [92].  The mature MBP, 
once in the periplasmic space of the organism, is now ready for its affinity interaction with the 
ligands (maltose and its higher homologs). 
 
2.6.4 Maltose/maltodextrin transportation by the MBP 
 
Maltose or maltodextrin will bind to the periplasmic MBP present in its open form (Figure 
2.7A).  This leads to a conformational change to the closed form (Figure 2.7B), and enables 
interaction with the transporter MalFGK2.  Binding to the transporter, in turn, stimulates a 
conformational change back to the open form.  The transporter opens at the periplasmic site with 
concomitant release of maltose into the transporter and the binding of ATP to the ATP-binding 
cassette, the MalK protein.  Since the open form of MBP has a low affinity for the transporter, it 
dissociates, thereby triggering the closure of the transporter at the periplasmic site and opening at 
the cytoplasmic site in a process driven by ATP hydrolysis [95].  Figure 2.6 illustrates the 
mechanism by which maltose is transported from the periplasm to the cytoplasm of a gram-
negative bacteria. 
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The maltose (represented by black spots) is first bound to the MBP transporting unit.  Upon 
contact with the membrane transporting system, composed of the MalF and MalG, a 
conformational change of the ATP binding cassette is triggered.  MBP then opens up to release 
the maltose.  Finally, the maltose is transported into the cytoplasm, a process driven by ATP 
hydrolysis [93]. 
 
 
 
PinkPink
Blue
Blue
Blue
Blue
Red
 
 
Figure 2.7: Diagrammatic representation of the open form (A) and the closed form (B) of the 
MBP [94]. 
Figure 2.6: Schematic representation of the maltose uptake system of the E. coli [93]. 
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The ribbon (red) present in the centre of the closed form represents the bound maltose.  The blue 
arrowheads show general regions of contact with the receptor, which are closely spaced in the 
closed form, but well-separated in the open form.  The pink arrows indicate the interface, that is, 
the site located directly opposite to the binding site.  Mutation of certain groups present in the 
interface has proven to have great influence on the MBP affinity for its ligands [95,96]. 
 
2.6.5 MBP as a solubility enhancer 
 
Some proteins are not amenable to overproduction in the cytoplasm of E. coli.  This is most 
probably because these proteins might either be toxic in the cytoplasm of the E. coli, or on the 
other hand, contain disulphide bonds.  For proteins with disulphide bonds, the periplasm of the 
E. coli has the advantage of providing a more reducing environment coupled with a variety of 
protein disulfide isomerases [97].  Moreover, most of these proteins, when overexpressed, form 
aggregates and inclusion bodies.  Protecting the expressed proteins from their hydrophobic 
environment and subsequent transportation to the periplasm of E. coli can be a possible solution 
to the problem of under-production of protein during protein expression. 
 
The best strategy to avoid insolubility or inclusion body formation during protein expression is 
to fuse the protein of interest to a protein known to be expressed at substantial levels in soluble 
form in E. coli.  The expression of the insoluble protein gene as a fusion partner to the protein-
dependent transport system of the E. coli (MBP) has been an effective recombinant technique for 
the large scale production of soluble, active protein [98].  Additionally, not only will the MBP 
facilitate the transportation of the expressed proteins from the cytoplasm to the periplasm of the 
organism to confer its solubility, they also play an active role in a one-step purification of the 
expressed proteins by virtue of the MBP affinity for solid-phase amylose [98].  As mentioned in 
Section 1.3, the expression of the ligand (hERLBD) as a fusion partner to MBP, will not only 
confer solubility to the ligand, but will provide a soluble, active affinity ligand that can be use for 
the capturing of EDCs. 
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2.7 CHARACTERIZATION OF ENDOCRINE DISRUPTING COMPOUNDS 
 
2.7.1 Introduction 
 
Over the past few decades there has been a significant increase in the number of chemicals in the 
biosphere capable of mimicking the action of endogenous hormones (such as estrogen) [99].  
These chemicals, known as EDCs, have the potential of disrupting the normal functioning of the 
endocrine system by interfering with the transport, biosynthesis and metabolism of the 
endogenous hormones.  Estrogenic compounds (ECs) are a class of EDCs that display estrogenic 
activity by mimicking the estrogen hormone.  These ECs have been linked to hormone-related 
diseases such as breast cancer, testicular cancer, low sperm count and feminization in both 
humans and wildlife [99-105].  In the endocrine system, steroid hormones generally carry out 
their functions by binding to the ligand-binding domain (LBD) of specific receptors.  Exploiting 
the interaction that occurs during the binding of endogenous hormones to their receptors can 
provide reliable and more specific methods for the detection and selective screening of potential 
environmentally toxic ECs. 
 
2.7.2 Effects of estrogenic compounds and their mechanism of action  
 
ECs, mimic the effects of estrogen hormones, resulting in abnormal responses [99-105].  These 
compounds, when bound to the endocrine receptors, do not only affect the reproductive system 
but are potential disruptors of other body organs such as the liver and heart [100,104].  The 
endocrine system controls and coordinates most of the basic human and animal development, 
differentiation and reproductive functions through hormones, secreted by ductless glands.  
Generally, these hormone signals tell “message receivers” in certain tissues (i.e. in reproductive 
organs, bones, the heart, adipose tissues), what to do.  The way these hormones bind to their 
receptors can be visualized as a key and lock mechanism.  The binding of a hormone to a 
specific receptor causes a conformational change in the receptor (i.e. causing the dissociation of 
the heat shock proteins), leading to the binding of the ligand receptor complex to the human 
hormone response element (HHRE) of the DNA.  Binding of the receptor to the DNA leads to 
co-activation of the receptor-DNA complex, followed by transcription then translation (Figure 
2.8).  Some compounds can mimic the hormones that normally bind to receptors.  Such 
interactions can lead to adverse effects [100-102], and hence these compounds are called 
endocrine disruptors. 
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Figure 2.8: Diagrammatic illustration of the mechanism of action of the endogenous hormones 
and the effect of EDCs on the mechanism of action: (A) Endogenous hormones traveling to their 
target cell and binding to their specific receptors; (B) interference of the endogenous hormones 
by hormones blocker (EDCs) from getting to their target receptors; (C) EDCs mimicking the 
action of the endogenous hormones. 
 
2.7.3 Structural and chemical properties of the estrogenic compounds 
 
ECs have a variety of purposes and forms.  The structures of these environmental estrogens are 
as varied as their functions.  Apart from the fact that they almost always have aromatic rings, 
they have no general similarity to the normal hormone structure.  Examples of these compounds 
include; diethylstilbestrol (DES), a pharmaceutical estrogen banned from use in the 1970s; 
coumestrol, a phytoestrogen that is a natural plant compound with some estrogenic tendencies; 
kepone (chlordecone), a synthetic pesticide banned in the United States; polychlorinated 
biphenyls (PCBs), used in electrical transformers and cooling systems; 4-nonylphenol (NP), a 
break-down product of detergents that are widely used in household products, industrial 
applications and plastics manufacturing; and O.p’-DDT, an isomer of the pesticide DDT.  This 
diversity in chemical structure (Figure 2.9) makes it difficult to predict the hormonal effect of a 
particular compound [103,104,33].  Other factors that increase the potency of these chemicals 
are their high fat solubility, low molecular mass and resistance to environmental breakdown, that 
enable the ECs to easily reach the site where they manifest their action.  Furthermore, these 
compounds lack visible characteristics, which make their identification and removal from the 
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natural environment difficult.  The occurrence of these compounds in some habitats, especially 
the environmental water supplies, poses a great threat to human health and wildlife. 
 
DDT
Bisphenol-A
-Sitosterol
Atrazine
Kepone
Nonylphenol
17-Estradiol
17-Ethinylestradiol
Butyl benzyl phthalate
3,3’4,4’-Tetrachlorobiphenyl
2,2’4,4’6-pentabromodiphenyl ether
Benzo[a]pyrene
2,3,7,8-Tetrachlorodibenzo-p-dioxin
Endosulfan
 
Figure 2.9: Compounds illustrating the structural diversity of chemicals in the environment 
reported to be estrogenic. 
 
 
2.7.4 Estrogenic compounds in water supply 
 
Scientists have in the past paid little attention to EDCs (which are less persistent) and focused 
their research work on persistent bioaccumulating toxic substances, which include dioxins, 
PCBs, and organochloride pesticides.  Lately, scientists have started to focus on a number of 
substances not so highly persistent, but still widespread in the natural environment.  These ECs 
can affect growth, reproduction, and development of organisms even at relatively low 
concentration in water [106].  There has also been some evidence that environmental disrupting 
chemicals exhibit synergistic effects; two weakly estrogenic compounds may combine to 
produce a stronger response [107].  These chemicals eventually permeate water supply through 
agricultural runoff since most of them are herbicides and pesticides.  Futher, some of these ECs 
are products of industrialization and may get into the water supply through leakage from storage 
tanks, accidental spillages or illegal dumping. 
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2.7.5 Techniques used for the detection of endocrine disruptors 
 
Much work has been carried out in recent years with the aim of improving the techniques used 
for the detection and quantification of ECs in the environment.  Some of these models include: 
solid phase extraction (SPE) performance with oasis cartridges, followed by liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS); SPE-gas 
chromatography-mass spectrometry (GC-MS); GC-MS/MS; high performance liquid 
chromatography (HPLC); HPLC-MS; HPLC-MS/MS; enzyme linked immunosorbent assay 
(ELISA); and ELISA-SPE [108,109].  Even though the above listed methods can be reliable, 
they have some potential drawbacks including the requirement of specialized workers, decreased 
robustness in nature, the inability to generate the solid matrix used, reduced accessibility, 
complex derivation, expensive clean-up and purification.  The high cost, time-consuming nature 
and complexity of these techniques lead to limitations in their application on large-scale 
operations in the field of selective detection and separation.  
 
To circumvent some of the shortcomings of the above-mentioned techniques, the concept of 
immobilized metal affinity chromatography was introduced, in which metals (mostly transition 
metals) were immobilized onto a matrix support by means of a ligand carrier through a covalent 
linkage [19,110-113].  Here, the metal ion attached to the carrier has one of its coordination sites 
open through which binding of the bio-macromolecules (proteins or enzymes) can take place.  It 
was with this mechanism that molecules could be selectively retained and separated.  This 
model, however, also had its shortcomings, such as the susceptibility of the metal ion to metal-
catalyzed oxidative reactions, structure of the affinity matrix, susceptibility of the matrix to 
reducing agents, pH, ionic strength and the position of the open coordination site of the metal ion 
[114,115]. 
 
Since ECs exert their effects by binding to the ligand-binding domain of the estrogen receptor, 
affixing hERLBD onto a matrix support will provide a viable alternative for the selective 
removal of these compounds from water.  In this study the hERLBD will be expressed as an 
MBP fusion protein.  The MBP will be used to immobilize the hERLBD on CA-amylose hybrid 
membranes.  This system will then be tested for the binding of ECs.  The cloning and expression 
of and MBP- hERLBD for this purpose will be described in the next Chapter. 
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CHAPTER 3 
EXPRESSION OF MBP AND MBP-hERLBD FUSION PROTEIN IN ESCHERICHIA 
COLI  
 
3.1 INTRODUCTION 
 
The most widely used and best-studied host system for high-level expression of proteins and 
recombinant proteins is the gram-negative bacteria, E. coli.  The E. coli expression system is a 
relatively simple system; it is inexpensive, has a fast high-density cultivation period, and its 
well-known genetics and numerous compatible tools available for biotechnology makes it a 
suitable system of choice for facilitated protein expression.  Unlike in the case of the expression 
of soluble proteins, major shortcomings have been encountered when using the host system for 
the expression of many heterologous proteins and proteins lacking compatibility with the E. coli 
cytoplasm [1]. 
 
Most proteins (especially from eukaryotes) expressed in E. coli are found as insoluble aggregates 
in inclusion bodies [2-18] and when overexpressed most of these proteins become biologically 
inactive.  This may be because the bacterium lacks the machinery for eukaryotic post 
translational modifications [19].  Formation of the aggregates or inclusion bodies may be 
attributed also to the formation of aggregates by the intermediates responsible for the folding of 
the proteins [20].  The solubility of a protein is one of the key properties determining its choice 
in functional and structural studies.  Thus, overcoming aggregation and formation of inclusion 
bodies during protein expression in the cell cytoplasm is very important. 
 
Regarding the aforementioned problems encountered during protein expression in the gram-
negative bacteria expression system, it is possible to enhance the solubility and stability of some 
of these proteins.  This can be achieve by reducing the induction temperature during expression 
and/or expressing the targeted protein as fusion proteins to fusion partners, such as the maltose 
binding protein (MBP) [21,22], glutathione S-transferase (GST) [23], hexahistidine [24,25] and 
thioredoxin [26].  These fusion partners are also advantageous in protecting the passenger or 
targeted proteins from intracellular proteolysis [27].  They may also serve as specific expression 
reporters [28,29].  The MBP has been cited by several authors as being a suitable fusion partner 
to GST, hexahistidine and thioredoxin since its fusion to proteins during expression helps to 
stabilize the expressed proteins, thus leading to an efficient functional expression of the proteins 
in the cell cytoplasm in a soluble, active form [31-40].  Not only are these fusion partners 
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responsible for stability and solubility of proteins during protein expression but most of them are 
also exploited for specific affinity purification strategies [27,31,41,42,43]. 
 
In this study the targeted protein hERLBD was expressed as a fusion protein to MBP.  MBP, 
being the main supplier of carbon to gram-negative bacteria, is known to have a great affinity for 
maltose and, in the absence of the maltose, has a great affinity for amylose.  The affinity 
chromatographic column used in this study was set up using amylose resin.  Purification of the 
recombinant protein was possible, since these proteins will couple (using the MBP) to the 
amylose column via affinity interaction.  Elution of the bound recombinant protein from the 
chromatographic column was done by adding maltose to the elution buffer, and since maltose 
has a greater affinity for MBP than amylose, it will displace the bound proteins from the column 
thus leading to the elution of the targeted proteins from the column. 
 
3.2 MATERIALS AND METHODS  
 
3.2.1 Reagents 
 
Trypton, yeast extract, agar, phenylmethanesulfonic acid (PMSF) and Coomassie brilliant blue 
(G250 and R250) were obtained from Fluka Biochemika (South Africa).  E. coli TB1 cells, 
pMalc2 plasmid vector, and amylose resin were purchased from New England Bio-labs (UK).  1, 
4-dithiothreitol (DTT), isopropyl--D-thiogalactopyranoside (IPTG) and HindIII were obtained 
from Roche Diagnostics (South Africa).  Sal I, EcoRI and BglII were purchased from Promega 
(South Africa).  Ampicillin and ammonium persulfate was purchased from Sigma Aldrich (South 
Africa).  Rainbow marker was obtained from Amarsham Life Science (South Africa) while 
ethylenediaminetetraacetic acid (EDTA) and QIAGEN Midi Kit 25 were obtained from BDH 
Chemicals (UK).  All the other chemicals were obtained from Merck (South Africa). 
 
3.2.2 Plasmid isolation and restriction digest assay 
 
All clones were transformed into E. coli TB1 competent cells.  For plasmid isolation and protein 
expression, 20 µl aliquots of the bacteria medium were streaked on agar plates containing 
ampicillin to a final concentration of 0.1 mg/ml and the plates incubated at 37°C overnight.  For 
a starter culture, a single colony from an overnight agar plate was used to inoculate 5 ml of LB 
medium containing ampicillin to a final concentration of 0.1 mg/ml, and cultivated on a shaker 
(300 rpm) at 37°C for 9 h. 
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Subsequently, plasmid isolation was performed following instructions obtained from the 
QIAGEN Midi Kit (25).  The plasmid harbouring the MBP was digested using two restriction 
enzymes, Hind and Bgl, while the plasmid containing the recombinant protein maltose 
binding protein human estrogen receptor alpha ligand binding domain (MBP-hERLBD) was 
digested using EcoR, Sal and Hind.  Figure 3.1 illustrates the ligation of the pMalc2 
expression vector with the insert (hERLBD) and Figure 3.2, the expected fractions after 
digestion of the plasmid with the appropriate restriction enzymes. 
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Figure 3.1: Diagrammatic representation of the pMalc2 expression vector showing the cloning of 
the insert hERLBD into the multiple cloning side (MCS) using two restriction enzymes Eco RI 
and SalI. 
 
The LBD gene cloned, from the alpha human estrogen receptor, is a protein consisting of 250 
amino acids with a molecular mass of approximately 25 kDa.  The gene was ligated into a 
plasmid expression vector pMalc2 and transformed into E. coli TB1 cells for expression.  The 
LBD was expressed as a fusion protein to fusion partner MBP a malE gene of molecular mass 
40.6 kDa and 370 amino acids. 
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Figure 3.2: Flow diagram illustrating the plasmid isolation of the pMalc2 recombinant plasmid 
from TB 1 E. coli cells expression host system, followed by restriction digestion using Eco RI, 
SalI and HindIII as restriction enzymes. 
 
3.2.3 Protein expression assay 
 
For the expression of MBP and the recombinant MBP-hERLBD fusion protein, cells were 
grown at 37°C in 100ml of LB medium (containing 100µg/ml ampicillin) to an absorbance of 
approximately 0.5 at 600nm with shaking at 300rpm.  Prior to induction, the temperature was 
adjusted to 25°C and the culture medium was allowed to reach the desired temperature.  
Expression was induced by the addition of IPTG to a final concentration of 0.3 mM.  Cells were 
subsequently incubated for an additional 12 h.  The cells were harvested from the culture 
medium by centrifugation at 4000 g for 20 min and pellets containing the desired expressed 
proteins were frozen at –20°C overnight until required for further analysis. 
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3.2.4 Cell disruption 
 
Frozen pellets were resuspended in lysis buffer (10 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 
1 mM DTT and 1 mM PSMF), 10 ml of lysis buffer per gram cells.  Chilled beakers containing 
the resuspended pellets were placed in a slurry of ice, NaCl and ethanol.  Cells were disrupted by 
sonication at 40 watts with 50% duty cycles for 10 min with 1 min interval using an ultrasonic 
cell disruptor sonicator (Branson Sonic Power Company).  The resulting cell lysate was 
centrifuged at 9000 g for 20 min at 4°C, with the supernatant containing the soluble extracts.  
 
3.2.5 Protein concentration determination (Pierce-method) 
 
Protein determinations were carried out according to the bicincoconic acid method using a Pierce 
protein™ determination kit according to the manufacturer’s instructions.  
 
3.2.6 Protein analysis by SDS PAGE 
 
Typically a 12 % acrylamide gel was prepared for SDS PAGE and cast in a Bio-Rad Mini-
protein® Cell for gel electrophoresis.  Prior to sample loading, all samples were treated with 
treatment buffer (0.125 M Tris-HCl pH 6.8, 4 % SDS, 20 % glycerol) and the resulting samples 
incubated at 90°C for 5 min.  After the application of samples to the gel (i.e. 20 g of 
protein/well), electrophoresis was carried out at 200 V.  The resulting gel was stained for 1h with 
Coomassie blue R-250 (0.125 % Coomassie blue R-250, 50 % methanol, 10 % acetic acid).  
Destaining was carried out first with destaining solution I (50 % methanol, 10 % acetic acid) and 
then destaining solution II (7 % acetic acid, 5 % methanol). 
 
3.2.7 Purification of the soluble extracts 
 
The MBP and the recombinant MBP-hERLBD expressed in E. coli were purified using a one-
step affinity purification system.  Unless stated otherwise all steps were carried out on ice.  
Briefly, amylose resin, with a binding capacity of 6.0 mg/ml bed volume, was used to pack a 
chromatography column (2.5 × 10 cm) to a height of 3 cm, corresponding to approximately 15 
ml of the resin.  The amylose resin column was equilibrated with 5 volumes of column buffer 
(20 mM Tris-HCL, 200 mM NaCl, 1 mM EDTA and 1 mM DTT) and its flow rate adjusted to 1 
ml/min using an Econo system controller (Bio-Rad).  Prior to sample loading, the sample was 
diluted 1:4 with the column buffer.  The diluted sample was loaded onto the column, and non-
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specifically and weakly bound proteins were removed by washing the column with 12 × column 
volume of the column buffer.  The bound proteins were eluted with the elution buffer (20 mM 
Tris-HCL, 200 mM NaCl, 1 mM EDTA, 1 mM DTT and 10 mM maltose), while collecting 
fractions at 10 min intervals for up to 2 h.  The purified samples were subjected to dialysis 
against a buffer (20 mM Tris-HCl pH 7.4, 50 mM NaCl and 1 mM EDTA) of low salt 
concentration for 24 h at 4°C.  Protein concentration and the SDS PAGE analysis was performed 
as described in Sections 3.2.5 and 3.2.6.  Figure 3.3 illustrates the steps used in the purification 
procedure of the fusion protein. 
 
Expression of 
recombinant protein
Affinity purification of 
recombinant protein
Elution of recombinant protein 
with 10 mM maltose
Amylose
resin
 
 
 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 Digestion of the recombinant plasmid 
 
The pMalc2 recombinant plasmid was digested using EcoRI and SalI because these were the two 
restriction enzymes used in creating the sites for ligating the hERLBD gene into the MCS of the 
vector.  Both enzymes digested the plasmid at unique positions since the inserted gene offered no 
EcoRI and Sal I restriction sites.  Analysing the above-mentioned restriction fragments on a 1% 
Figure 3.3: Diagrammatic illustration of the purification procedure of the MBP-hERLBD using 
the affinity chromatography technique. 
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agarose gel indicated a single band at position 750 bp, corresponding to the size of the inserted 
gene, and another band at 6578 bp ascribed to the pMalc2 backbone (Figures 3.2 and 3.4).  The 
Hind III confirmed that the plasmid was inserted in the correct orientation.  Hind III digested the 
plasmid at two positions: on the pMalc2 backbone and within the inserted gene.  A band 
corresponding to approximately 700 bp on a 1% agarose gel, indicated that the gene was inserted 
in the correct orientation (Figures 3.2 and 3.4). 
 
 
hERLBD fragment at ~750bp
1   2   3   4   5   6   7  8
 
 
 
 
 
 
 
3.3.2 Digestion of the pMalc2 plasmid 
 
The pMalc2 vector harbours the malE gene which encodes for the MBP.  In order to verify the 
presence of the malE gene the plasmid was digested with two restriction enzymes Bgl II and 
Hind III, which cut the plasmid at two positions, 1962 bp and 2803 bp, respectively.  Analysis of 
the digest on a 1% agarose gel indicated two broad bands at positions 5806 bp and 840 bp, 
illustrating a positive confirmation of the presence of the malE gene in the pMalc2 vector (Figure 
3.5). 
 
 
Figure 3.4: Restriction digestion of pMalc2-hERLBD with EcoR1, SalI, and HindIII.  Lane 2: 
pMalc2-hERLBD uncut, lane 3: pMalc2-hERLBD cut with EcoRI, lane 4: pMalc2-hERLBD 
cut with SalI, lane 5: 1kb marker, lane 6: pMalc2-hERLBD cut with SalI and Eco RI, and lane 7: 
pMalc2-hERLBD cut with Hind III.  Lanes 1 and 8 were empty. 
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MBP fragment at ~ 840 bp
 
 
 
 
 
 
3.3.3 Protein expression and purification 
 
The concentrations of MBP and MBP-hERLBD, expressed in E. coli, were 6.44 and 5.73 
mg/ml respectively. 
 
With positive results obtained from the plasmid isolation, E. coli TB1 cells harbouring pMalc2 
vectors containing MBP-hERLBD and MBP were cultured for the expression of the two 
proteins.  Results obtained from SDS-PAGE analyses of the two respective cell lysates are given 
in Figures 3.6 and 3.7.  A band corresponding to an apparent molecular mass of 66 KDa (Figure 
3.6) was in good agreement with the molecular mass of MBP-hERLBD reported in literature, 
while the band corresponding to an apparent molecular mass of 42 KDa (Figure 3.7) was in good 
agreement with the reported molecular mass of MBP. 
Figure 3.5: Restriction digestion of pMalc2 vector with Bgl II and Hind III.  Lane 3: pMalc2 
vector uncut, lane 4: pMalc2 vector cut with Bgl II, lane 5: vector cut with Hind III, lane 6: 1 kb 
marker and lane 7: plasmid vector cut with Bgl II and Hind III.  Lanes 1,2 and 8 were empty. 
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Figure 3.6: SDS-PAGE gel showing the protein molecular mass markers (lanes 1 and 6), the 
insoluble product of the protein lysate (lane 2), the uninduced samples (lane 3), and IPTG 
induced E. coli protein lysates (lanes 4 and 5).  
 
Figure 3.7: SDS-PAGE gel showing the protein molecular mass markers (lanes 1 and 6), the 
insoluble product of the protein lysate (lane 2), the uninduced samples (lane 3), and IPTG 
induced E. coli protein lysates (lanes 4 and 5). 
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The MBP-hERLBD fusion proteins and the MBP proteins were purified on an amylose column 
by affinity chromatography.  The coupled fusion protein was eluted from the affinity column by 
including 10 mM of maltose in the elution buffer.  Figure 3.8 shows the loading and elution 
profiles of the proteins during the affinity purification procedure. 
 
According to the SDS-PAGE analysis (Figure 3.9), MBP and the recombinant MBP-hERLBD 
proteins migrated corresponding to molecular masses of 42 KDa and 66 KDa respectively.  
These molecular masses corresponded exactly to those seen on the expression gel for the MBP-
hERLBD protein (Figure 3.6) and the MBP protein (Figure 3.7). 
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Figure 3.8: The elution profile of the MBP-hERLBD after elution from the affinity column with 
a maltose buffer (20 mM Tris-HCL, 200 mM NaCl, 1 mM EDTA, 1 mM DDT, and 10 mM 
maltose).   
 
 
 
Stellenbosch University http://scholar.sun.ac.za
 51 
1  2  3   4   5   6   7   8KDa
75
50
 
 
 
3.4 CONCLUSIONS 
 
This study showed that MBP-hERLBD ligated into the pmalc2 plasmid, and the MBP gene 
(malE product) from the pmalc2 plasmid can be expressed in high yield using the E. coli 
expression system.  It also showed the application of a one-step affinity purification system with 
amylose as the solid phase for the effective purification of these proteins.  These purified 
proteins will subsequently be used to raise antibodies, which will be used to investigate the 
immobilization of the expressed proteins on a modified cellulose acetate membrane, for the 
ultimate binding and removal of EDCs by the MBP-hERLBD immobilized fusion protein. 
 
 
 
 
 
 
 
 
Figure 3.10: SDS-PAGE gel of the purified MBP/MBP-hERLBD samples. Lanes 2, 3 and 4 
are indicative of the purified MBP fusion protein loaded on the SDS-PAGE gel at different 
concentrations, while lanes 5, 6 and 7 are indicative of the purified MBP-hERLBD fusion 
protein.  The protein molecular mass marker in lanes 1 and 8 was used to determine the size of 
the proteins in the respective bands. 
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CHAPTER 4 
IMMUNOLOGICAL STUDIES WITH MBP-hERLBD  
 
4.1 INTRODUCTION 
 
Antibodies are specific molecules used in some biological applications for both quantitative and 
qualitative analyses [1].  The increased use of these biological molecules means that their 
production is of great importance.  The process involved in the production of the antibodies is 
generally termed as immunisation.  The antibodies produced from the immunisation process can 
selectively and specifically interact with other molecules generally termed as antigens [1-3].  The 
interactions between the antibodies and the antigens are generally required for analytical 
techniques such as enzyme-linked immunosorbent assays (ELISA), immunoblotting, 
immunoprecipitation, immunochemistry and also in studies involving the structural relationship 
between proteins.  Generally, two types of antibodies are produced from the immunisation 
process: polyclonal and monoclonal antibodies.  These two antibodies have proven to be very 
effective in a number of different applications, but there are distinct advantages and 
disadvantages associated with using each type of antibody for a particular study. 
 
A problem often encountered in the production of polyclonal antibodies is that relatively large 
amounts of the protein are required for the immunisation process.  In most cases these proteins 
are available in very small amounts that are insufficient for standard immunisation protocols [4].  
The use of acid-treated or naked bacteria as immune carriers for proteins is an approach to 
specific antibody production aimed at overcoming the aforementioned problem [4].  In this 
approach, the natural antigenic determinants of Salmonella minnesota R595 are selectively 
stripped by mild hydrolysis generating an outer hydrophobic cell wall surface [4,5].  The 
hydrophobic cell wall will facilitate the interaction of hydrophobic antigen on the acid treated 
bacteria through hydrophobic interaction.  The use of acid-treated bacteria as immune carriers 
has shown that they possess a strong immunostimulatory activity, making it possible to use less 
protein-antigen for the immunization procedure [4,5]. 
 
In this study, polyclonal antibodies will be raised against the recombinant protein (MBP-
hERLBD) by immunizing a rabbit with the MBP-hERLBD naked bacteria complex.  Upon 
achieving this and determining the specificity of these antibodies, they will be used to investigate 
the immobilization of the purified proteins (MBP and MBP-hERLBD) on a functionalized 
cellulose acetate membrane. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 Reagents 
 
Monoclonal rat anti hERLBD antibody was a gift from Z. Allie (Department of Biochemistry 
University of Stellenbosch).  All other reagents used in the following experiment were of 
biological grade and obtained either from Merck or Sigma, unless otherwise stated. 
 
4.2.2 Adsorption of MBP-hERLBD fusion protein onto the naked bacteria 
 
Purified MBP-hERLBD proteins were adsorbed to the hydrophobic walls of the naked bacteria 
to evoke an immune response [1].  A fine suspension of 2 mg/ml of the bacteria was prepared 
from Salmonella minnesota R595, by gentle homogenization of the freeze-dried bacteria in 
sterilized Milli-Q® water.  The purified MBP-hERLBD was dissolved in sterilized Milli-Q® 
water to a final concentration of 1 mg/ml.  The MBP-hERLBD solution was added to the 
bacteria suspension to give a 5:1 ratio of naked bacteria-MBP-hERLBD complex.  The mixture 
was then dried on a rotary evaporator.  The naked bacteria-MBP-hERLBD complex thus 
formed was resuspended in phosphate buffer saline (PBS) to a final concentration of 200 µg of 
naked bacteria- MBP-hERLBD complex/ 0.5 ml PBS, pH 7.2.  Prior to immunization, a 120 µg 
naked bacteria- MBP-hERLBD complex/ 0.5 ml PBS, pH 7.2 suspension was prepared and 500 
µl of the suspension was used per immunisation. 
 
4.2.3 Antibody production against MBP-hERLBD fusion protein 
 
Immunization of a rabbit with the naked bacteria-MBP-hERLBD complex was affected 
intravenously in the marginal ear of the rabbit.  The rabbit was bled before immunisation was 
commenced and the sera collected (day zero sera) were used to correct antibody titre for non-
specific binding.  After the collection of the day zero sera, the rabbit was injected with 200 µg of 
the protein-bacteria complex on days 0, 3, 7, 14, 17 and 22.  Two millilitres of blood was drawn 
from the central artery of the rabbit’s left ear on day 28.  This was followed by a further injection 
of the rabbit with 200 µg of the protein-bacteria complex on days 28, 31, and 37.  The rabbit was 
test bled on day 43 and a large volume of blood was collected on day 45.  All blood samples 
collected were later tested for antibody activity using an ELISA assay (Figure 4.2). 
 
 
Stellenbosch University http://scholar.sun.ac.za
 58 
4.2.4 Enzyme-linked immunosorbent assay  
 
The quantitative measurement of anti-MBP-hERLBD in serum over time was performed 
applying the ELISA kit (Nunc Immunoplate I) according to the manufacturers’ instructions.  The 
micro titre plate wells were coated with 100 µl of the protein antigen (purified MBP-hERLBD) 
diluted to an optimal concentration in carbonate buffer (pH 9.6).  The micro titre plate was then 
incubated at 4˚C overnight.  The contents of the wells were removed and the wells blocked for 
one hour at 37˚C by the addition of 200 µl casein buffer (10 mM Tris-HCl, 0.15 M NaCl, 0.02% 
thiomersal and 0.5% casein) in each well.  The contents of the wells were removed and rinsed 
thrice with PBS-Tween 20 buffer (1.4 mM KH2PO4, 8 mM Na2HPO4, 140 mM NaCl, 2.7 mM 
KCl, pH 7.3 and 0.05% Tween-20). 
 
A dilution series of the sera (ranging from 1 in 20 to 1 in 10 240) was prepared in casein buffer 
and 100 l dispensed into each well.  The plate was incubated at 37˚C for 1 h.  The contents of 
the wells were removed and the wells washed three times with PBS-Tween 20 buffer.  This was 
followed by the addition of 100 µl of the donkey anti-rabbit secondary antibody diluted 1:10 000 
times in casein buffer, and the plate was incubated at 37˚C for 1 h.  After the incubation period, 
the secondary antibody solution was removed and loosely adherent ones were washed off as 
before.  Subsequently, 100 µl of the enzyme substrate, 2,2’-azino-di-(3-ethylbenzenethiazoline-
6-sulphonate) (ABTS) and H2O2 in citrate buffer (pH 5) was added to each well, and the plate 
was incubated at room temperature for 30 min.  The absorbance of the contents of each well was 
measured at 405 nm on a micro titre plate reader.  The colour changes observed on the plate 
upon addition of the substrate solution were proportional to the amount of specific rabbit anti-
MBP-hERLBD dependent enzymes antibodies.  Figure 4.1 illustrates the steps involved in 
antibody production and characterization. 
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4.2.5 Immunoblott analysis  
 
The purified protein fractions referred to in Chapter 3, i.e. maltose binding protein (MBP) and 
the MBP-hERLBD fusion protein were subjected to a 12% SDS-PAGE analyses.  Upon 
completion of electrophoresis, one of the gels was stained with Coomassie brilliant Blue (R-250) 
to confirm the presence of the protein of interest, and the other (unstained) gel was 
electrophoretically transferred to a nitrocellulose membrane, using a wet transfer system (17 h at 
120 mA).  The gel was carefully positioned on the nitrocellulose membrane after which the 
membrane and the gel were “sandwiched” between blotting papers and “Scotch guard”.  The 
assembly was supported and secured in place by two Perspex plates, and the entire assembly was 
placed in a transfer chamber pre-filled with transfer buffer (25 mM Tris, 195 mM Glycine, 10% 
methanol, pH 8.3) in such a way that the gel was closest to the cathode and the nitrocellulose 
membrane closest to the anode.  The resulting nitrocellulose membrane was used for the 
identification of the MBP, MBP-hERLBD antigens by immunoblotting procedure with the 
specific antibody raised against the MBP-hERLBD antigen (see Section 4.2.3). 
Figure 4.1: Diagram showing the production of antiMBP-hERLBD and an ELISA assay 
performed using the antiMBP-hERLBD. 
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Prior to the identification of the proteins transferred to the nitrocellulose membrane with the 
specific ligand (rabbit anti-MBP-hERLBD antibody), all the unoccupied binding sites on the 
membrane were blocked using casein buffer (10 mM Tris pH 7.6, NaCl 0.15 M, thiomersal 
0.02% and casein 0.5%) to prevent any non-specific binding of protein.  The blocked 
nitrocellulose membrane was incubated with the primary antibodies (rabbit anti-MBP-
hERLBD) at 37˚C for 1 h in casein buffer (1:10 000).  The unbound antibodies were removed 
and the membrane was washed three times with TBST buffer (25 mM Tris, 150 mM NaCl, pH 
7.6, and 0.05% Tween-20).  The membrane was subsequently incubated with secondary 
antibodies (goat anti-rabbit-HRP) in casein buffer (1:10 000) for 1 h at 37˚C.  After incubation, 
loosely adherent secondary antibodies were washed off the membrane as before.  Antibodies 
binding MBP-hERLBD were identified by enhanced chemiluminescence.  Briefly, upon 
completion of probing, the membrane was sandwiched between two transparencies, exposed at 
different time frames, transferred into the developer and finally into the fixer for clear 
visualization of the blot (Figures 4.3[1] and 4.4). 
 
Protein bands on the nitrocellulose membrane were also visualized, not using the 
chemiluminescent luminol substrate, but rather 4-chloro-1-naphtol and H2O2, in PBS.  The 
reaction was terminated after 10 min by washing the nitrocellulose membrane with distilled 
water (Figure 4.3[2]).  In this reaction, the development of the colour was due to the reaction 
between H2O2 and the peroxidase leading to the release of an oxygen radical, which in turn leads 
to the formation of a double bond in 4-chloro-1-naphtol. 
 
4.3 RESULTS AND DISCUSSION 
 
For further analytical experiments on the purified MBP-hERLBD, polyclonal antibodies were 
raised against the MBP-hERLBD.  This was achieved by adsorbing the MBP-hERLBD 
antigen onto acid-treated naked bacteria and subsequently injecting the complex into a rabbit for 
anti-MBP-hERLBD antibody production.  The immune response over time was studied using 
an ELISA assay (Figure 4.2).  High antibody titres were observed at day 45 of the immunization 
(Table 4.1).  The resulting anti-MBP-hERLBD antibodies were used in immunoblotting 
experiments to determine if the polyclonal antibodies could recognise its antigen.  Results 
obtained from these experiments showed that the generated polyclonal antibodies could 
specifically recognise the MBP-hERLBD antigen (Figures 4.3[1] and 4.3[2]).  The result also 
showed some degree of cross-reactivity.  This cross-reactivity could be attributed to the 
impurities present with the antigen during the immunization procedure. 
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Although the polyclonal antibodies were raised against the recombinant protein (MBP-
hERLBD), it was interesting to note that the anti- MBP-hERLBD antibodies could recognise 
both the recombinant form of the protein (lanes 2-5 and lanes 5-7 of Figures 4.3[1] and 4.3[2] 
respectively) as well as the single protein MBP (lanes 7-10 and lanes 2-4 of Figures 4.3[1] and 
4.3[2] respectively).  Figure 4.2 and Table 4.1 summarize the immune response over time of the 
rabbit injected with the fusion protein. 
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Figure 4.2: Curve illustrating the immune response of a rabbit immunized with MBP-hERLBD 
fusion protein. 
 
Table 4.1: Calculated titre values obtained from the immune response curve of a rabbit 
immunized with MBP-hERLBD fusion protein 
 
Days 0 28 43 45 
Titres  
(1: 2yX10) 
0 10.1 10.3 12.4 
 
 
To confirm the presence of the MBP-hERLBD antigen, monoclonal antibodies raised against 
the human estrogen receptor ligand binding domain (hERLBD) were used as control during the 
immunoblotting experiment.  Results obtained showed that the monoclonal antibody had 
recognisable functional groups (epitope) for the MBP-hERLBD antigen (Figure 4.4[1]) but not 
for MBP (Figure 4.4[2]). 
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Figure 4.3: SDS-PAGE gels A with their corresponding immunoblots B.  (1) represent 
immunoblot assays using enhanced chemiluminescence technique and (2) represent immunoblot 
assay using immunofixation technique.  Raised polyclonal anti MBP-hERLBD antibodies were 
used as the secondary antibody in both immunoblots.  Lanes 2-5 of (1) represent bands of MBP-
hERLBD and 7-10 represents MBP, while lanes 2-4 and 5-7 of (2) are bands corresponding to 
MBP and MBP-hERLBD respectively.  
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Figure 4.4: SDS-PAGE gels A with their corresponding immunoblots B. Moclonal rat anti 
hERLBD antibodies were used as the secondary antibody in both immunoblots.  (1) represent 
immunoblot assays using MBP-hERLBD antigen (lanes 2-6) and (2) represent immunoblot 
assay using MBP antigen (lanes 2-4).   
 
 
 
4.4 CONCLUSIONS 
 
In this study, polyclonal anti MBP-hERLBD antibody was successfully raised by immunizing a 
rabbit with MBP-hERLBD acid-treated naked bacteria conjugate.  Results obtained from the 
immune response curve depicted the highest titre value on day 45 of the immunization.  The 
MBP protein was recognised by the polyclonal antibody, because of the MBP epitopes present 
on the antibody.  To further confirm the viability of the raised polyclonal antibody, monoclonal 
rat anti hERLBD antibody was used.  Results from this experiment revealed that the rat anti-
hERLBD monoclonal antibody could recognize the hERLBD of the purified MBP-hERLBD 
fusion protein but not the MBP.  However, based on the recognition of the rabbit anti MBP-
hERLBD antibody for both MBP and MBP-hERLBD, and using MBP and MBP-hERLBD as 
the immobilizing ligands, the rabbit anti MBP-hERLBD antibody was preferred to the 
monoclonal rat anti-LBD antibody through out this experimental work.  The polyclonal rabbit 
anti MBP-hERLBD antibody will be used as a potential ‘marker’ to investigate the 
immobilization of the purified proteins on a modified cellulose acetate membrane for the 
ultimate binding and removal of EDCs by the MBP-hERLBD immobilized fusion protein.  To 
support the aforementioned ideas, an analogous system has been described previously wherein 
LBD was utilized as a receptor to selectively capture analyte target specific for the LBD.3 
 
                                                    
3
 http://www.patenstorm.us/patents/6500629/fulltext.html. 
A A B B 
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CHAPTER 5 
FABRICATION OF A CELLULOSE ACETATE MEMBRANE MODIFIED WITH 
AMYLOSE FOR MBP IMMOBILIZATION 
 
5.1 INTRODUCTION 
 
Cellulose acetate membranes have become increasingly popular in the biomedical and 
biotechnology fields.  These membranes are used in a wide range of applications due to their 
good performance in permeability, mechanical stability and their versatile nature [1-13].  
However, grafting of protein molecules on the surfaces of these membranes can induce 
decreasing water and solute permeability, and a series of biochemical reactions [14].  Other 
shortcomings of these membrane matrices include: lack of biospecificities of some of the affinity 
ligands, less resistance of ligands to harsh chemicals and temperatures, difficulty to clean up, and 
insufficient ligand binding capacity of the support.  To reduce some of the aforementioned 
shortcomings, several different approaches have been used in the fabrication of the membrane 
matrices [15-17]. 
 
Each application dictates specific requirements on the membrane materials and structure.  
Selection of the correct material for membrane fabrication requires an in-depth understanding of 
the membrane material to be used as well as an understanding of both the biomolecule and 
immobilizing molecule (in case of affinity separations).  Generally there are several techniques 
used in the fabrication of synthetic polymeric membranes.  Some of the techniques used are: 
 
• thermally induced phase separation [18]; 
• air-casting of a polymer solution [18,19]; 
• precipitation [18]; and 
• immersion precipitation [18, 20, 21]. 
 
In this study, based on the interaction occurring between the membrane matrix and the 
immobilized ligand, a novel membrane matrix of CA modified with amylose will be fabricated 
using the immersion precipitation technique.  
 
Several fundamental studies have been put in place to investigate the effects of membrane 
surface properties such as pore size, pore size distribution, electrokinetic characteristics, surface 
roughness, chemical properties and specific chemical structure [22-26].  Some of the techniques 
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used for membrane properties characterization include: atomic force microscopy (AFM) and 
scanning electron microscopy (SEM) (surface roughness, structure, topography) [27, 28], X-ray 
photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FT-IR) (surface 
chemical functional groups) [29-31], nuclear magnetic resonance (NMR) spectroscopy 
(permeability), contact angle [32,33], Raman spectroscopy (structure) and electron spin 
resonance (solute mobility in membrane polymer matrix and pores) [22].  However, despite the 
various techniques used in characterization of the membrane surface properties, there is no single 
technique which can fully characterize membrane surface substructure.  In this study, two 
analytical techniques (SEM and FT-IR) will be used for the characterization of the modified CA 
membrane.  
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Reagents 
 
DMSO was obtained from BDH chemical (UK).  The amylose resin was purchased from Fluka 
(South Africa), while the cellulose acetate was obtained from Prof EP Jacobs from the Polymer 
Department, University of Stellenbosch (South Africa). 
 
5.2.2 Membrane fabrication 
 
An amylose functionalized CA membrane was fabricated from a mixture containing 25% m/m 
CA, 2% m/v and 4% m/v amylose respectively, 90% dimethyl sulfoxide (DMSO) and 10% H2O.  
The CA and the amylose were dissolved in DMSO and H2O by stirring at 75ºC for 1 h.  The CA 
and amylose solutions were pooled in known proportions and stirred for 30 min to form a casting 
mixture.  The casting mixture was subsequently degassed overnight and then used to cast flat-
sheet membranes by immersion precipitation using a suitable solvent (Milli-Q® water).  The 
membranes were thoroughly washed with Milli-Q® water and stored in an aqueous 2%v/v 
sodium azide solution until required.  The surface membrane topography, thickness and 
functional groups modification were determined using SEM and FT-IR respectively.   
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5.2.3 Membrane characterization 
 
5.2.3.1 Scanning electron microscopy 
 
The surface structure of the fabricated membranes was characterized using SEM.  Membrane 
samples approximately 1 cm2 were freeze-dried in liquid nitrogen.  The resulting freeze-dried 
samples were gold plated, mounted onto a plate holder before loading into the LEO-1430PV 
SEM chamber for imaging.  The images were generated as a result of the interaction between 
highly energetic electron beam from the instrument and the gold plated membrane surface.  The 
characterization of the fabricated membranes using the SEM will yield information such as; the 
surface features of the membranes, their textures and direct relation between the features and 
material properties (hardness, reflectivity).  The aforementioned information was used to 
evaluate the differences in topography between the different fabricated membranes. 
 
5.2.3.2 Photo-acoustic Fourier transform infrared spectroscopy  
 
The photo-acoustic Fourier transform infrared (FT-IR) system was used to characterize the 
surface composition of the hybrid membrane.  The samples were placed in a sample cup holder 
and subsequently introduced into a MTEC 300 chamber, allowing as little air into the sample 
component as possible.  The samples were later flushed with high-purity helium and the spectra 
obtained were recorded on a Perkin Elmer Paragon 1000 FT-IR apparatus.  The membrane 
samples were analysed based on the interferometric detection of light intensity that is transmitted 
through the membrane and the Fourier transformation.  The parameters used for the analyses are 
tabulated in Table 5.1.  Information from the FT-IR was used to compare the differences 
between the functional groups of the different fabricated membranes. 
 
Table 5.1: Parameters used for FT-IR analysis of the CA membrane 
 
FT-IR parameters Values 
Mirror velocity (OPD) 0.1 cm/s 
Resolution 8 cm-1 
Source aperture maximum 
Spectral range  400 - 4000 cm-1 
Number of scans 128 
Sample reference Carbon black 
Detector gas atmosphere Helium 
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5.3 RESULTS AND DISCUSSION 
 
5.3.1 Scanning electron Microscopy 
 
Quantitative information on membrane topography and morphology were investigated by SEM 
imaging.  Figure 5.2 depict clearly the differences in surface morphology between the fabricated 
membranes.  Figure 5.2a depict membrane formed from a casting dope of CA while Figures 5.2b 
and 5.2c depict membranes formed from a casting dope containing CA and amylose, with the 
amylose present at concentrations of  either 2% m/v or 4% m/v. 
 
The first observation shown by the SEM images is the differences in the pore size and pore size 
distribution.  The sizes of the pores increased with an increase in amylose content.  The average 
pore sizes were 1.58 µm and 2.61 µm for CA membrane with 2% m/v and 4% m/v amylose 
respectively.  Some research groups suggest that pore formation in composite membranes is as 
result of nucleation and growth of the polymer-lean phase in the liquid-liquid delayed demixing 
of the polymer solution during inversion [16,17].  Based on the above, it is suggested that the 
increase in amylose content in polymer solution causes a delay in demixing hence leads to 
increased pore formation.  Figure 5.2 depict membrane surface images obtained from the SEM 
analysis.  
 
a b c
Mag = 10.00kX
2 µm
Mag = 10.00kX
2 µm
Mag = 10.00kX
2 µm
 
Figure 5.1: SEM images of (a) a CA membrane and (b and c) CA/amylose hybrid membranes 
with (a) 2% (m/v) and 4% (m/v) amylose respectively. 
 
5.3.2 Photo-acoustic Fourier transform infrared spectroscopy 
 
It is important to characterize the chemical functional groups on a membrane surface when 
membranes are to be used for a particular application [27].  The functional groups of the 
described membranes were characterized using photo-acoustic spectroscopy (PAS) FT-IR.  This 
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technique requires little or no sample preparation for high quality spectra and no alignment of the 
infrared incident beam was necessary during the experimental procedure.  PAS FT-IR spectra of 
the membranes are included in the appendix. .  Figures A1 to A8 in the appendix were used to 
contrast the differences between the CA and CA/amylose membrane surfaces, the CA and 
amylose powder and also to observe the most prominent changes in terms of functional groups 
when the percentage of amylose was increased from (10-15)% in the CA membrane. 
 
All FT-IR spectra, apart from the intense peak observed at 1642.25 cm-1 (corresponding to C=O, 
C=C, H-O-H stretching) on the amylose powder spectrum, were similar to each other.  The 
spectra can be categorized to three main regions with respect to the stretching vibrations 
occurring within these areas.  Firstly, peaks observed at the region 2 850-3 650 cm-1 
corresponded to the –CH3, –CH2, –CH and –O-H groups, chemical groups characterizing the 
cellulose and amylose backbone.  Secondly, a broad peak was observed at region 2 000-2 500 
cm-1 corresponding to the C-C-O ester stretching.  This potion indicate the presence of the 
acetate group present in the CA since this same peak was absent in the amylose powder 
spectrum.  Lastly, a characteristic peak was observed at the region 1700-1800 cm-1 corresponded 
to the C=O stretching.  No other deductions could be made from the spectra given the similarity 
between cellulose and amylose (Figure 5.3). 
 
B
acetyl
groups
Links to other 
cellulose groups
Links to other 
cellulose groups
A
 
 
 
 
 
 
Figure 5.2: Structural representation of cellulose acetate (A) and amylose (B), with the acetate 
group occurring as the only difference between the two structures. 
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As shown from another FT-IR analysis using a CA membrane, CA/1% amylose and 
CA/2% amylose membranes, result revealed a notable single peak in the 1 700-1 800 cm-1 region 
for the various membranes used.  As the concentration of the amylose in the membrane was 
increased, the intensity of the peak at 1 755 to 1 741.90 cm-1 decreased.  This could be due to the 
fact that the amylose shields the C=O stretching groups of the cellulose acetate.  This difference 
in peak intensity gives an indication of the presence of amylose in the membrane. 
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Figure 5.3: FT-IR spectra of a CA membrane, CA/1% amylose membrane and CA/2% amylose 
membrane. 
 
5.4 CONCLUSIONS 
 
In the present study, both CA and amylose powers were successfully dissolved in a 90% DMSO 
and 10% H2O solution.  The resulting mixture was successfully used as a casting dope for the 
fabrication of a CA/amylose functionalized membrane using the immersion precipitation 
technique.  The membrane topography and morphology was studied with the aid of the SEM 
technique, while the surface chemistry of the membrane was monitored with FT-IR.  Following 
the information obtained from the membrane morphology and surface chemistry the membrane 
could be used for affinity immobilization of the specific bio-ligands MBP and MBP-hERLBD 
fusion proteins.  Membranes containing higher percentages of amylose were ductile, fragile and 
therefore could not be used as solid supports for further experimental analyses.  Therefore in the 
present study, only a 2% amylose membrane was used for the immobilization study.  In future, 
however, higher percentages of amylose could be incorporated into the CA membrane but this 
will be followed by using some plasticizer to render the membrane more resilient to physical 
dmage and deformation [34-37].  
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CHAPTER 6 
ASSESSING THE VIABILITY OF THE IMMOBILIZED MBP/MBP-hERLBD FUSION 
PROTEIN USING RADIOACTIVE ESTRADIOL 
 
6.1 INTRODUCTION 
 
Large sets of genomic and proteomic samples constantly generated has lead to a need for tools 
that will facilitate rapid screening and analysis.  Selective screening and/or purification of these 
biological molecules from their natural environment poses serious problems in the field of 
biotechnology.  This has lead to the development of techniques which are cost effective, robust 
and specific for the purification of these samples.  The immobilization of proteins and other 
biological molecules on solid matrices is constantly and increasingly being used as a suitable 
method of this purpose.  During the immobilization procedures, the proteins and/or other 
biological molecules are immobilized on a carrier surface either covalently by attachments to 
activated groups or passively through ionic interaction [1].  The immobilized ligand is usually 
specific for a particular application.  
 
Immobilization technology has been widely used in many different areas of biotechnology e.g. 
the immobilization of molecules in ELISA assays, diagnostics, biosensors, affinity 
chromatography and immobilization of molecules onto nanoparticles for drug/gene delivery [2-
6].  Immobilization of macromolecules on a micro porous membrane as a solid surface is 
constantly being used.  The reason for this being that membrane surfaces offers low diffusional 
resistance, high compressibility and chemical stability to harsh conditions of adsorption, elution 
and regeneration [2].  However, the retention and structural integrity of the immobilized 
macromolecule still present some challenges [1].  Common to most immobilization systems is 
the application of one or more thermochemical/chemical steps.  Reagents used in these steps may 
have the potential of degrading the structure and/or function of the immobilized protein [7-11].  
There is a rising need to improve on or to development new immobilization techniques where the 
functional/ structural properties of the immobilized components are retained.  Thus, designing a 
system to be use for immobilization, there are certain factors which must be taken into account.  
Some of which include [12-14]: 
 
 the type of solid support to be used; 
 the orientation of the bound protein; 
 the flexibility of the bound protein; 
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 the concentration of the immobilized ligand; 
 the solvent compatibility (in case of hybrid support); and 
 the interaction between the solid interface and the immobilized ligand etc. 
 
In this study MBP-hERLBD fusion protein will be immobilized to an amylose functionalized 
membrane with the amylose present in the membrane surface offering the binding sites for the 
MBP-hERLBD immobilization since MBP has an affinity for amylose.  Also included herein, 
will be the application of the membrane system for the selective recovery of estradiol from 
solution. 
 
6.2 MATERIALS AND METHODS 
 
6.2.1 Reagents 
 
[2,4,6,7-3H (N)] 17- estradiol (250 uCi, 100.0 Ci/mmol) was obtained from PerkinElmer 
(Boston MA02118 USA), -Estradiol from Fluka chemie GmbH, progesterone was obtained 
from Sigma-Aldrich Chemie GmbH, NaCl, NaOH, Tris-HCl and EDTA were obtained from 
Merck.  
 
6.2.2 Amylose/E2 binding assay 
 
Prior to the CA/amylose flat-sheet membrane binding assay, the activity and binding of the 
recombinant protein, MBP-hERLBD, onto the resin was tested using radioactive 17- estradiol 
(E2).  Briefly, amylose resin was equilibrated with buffer A (20 mM Tris-HCl pH 7.4, 0.1 M 
NaCl and 0.1 mM EDTA) to yield a working slurry.  For the determination of the E2-binding, 
300 µl of the amylose slurry was incubated overnight at 40°C with extract containing MBP-
hERLBD, diluted to approximately 0.1 mg/ml using buffer A.  [3H]–Estradiol working solution 
was prepared by diluting 10 µl of [2, 4, 6, 7-3H (N)] 17--estradiol (250 uCi, 100.0 Ci/mmol) 
obtained from the manufacturer with 10 µl of non-radioactive 1 × 10-3 M 17--estradiol in 96% 
ethanol.  The organic solvent content was reduced to approximately 1 µl using a stream of dry 
nitrogen gas and subsequently diluted with buffer A to yield [3H]-E2 working solution of 2.44 × 
10-5 M.  Prior to E2 binding, the amylose/MBP-hERLBD slurry was washed three times for 4 
min each using chilled 50 mM Tris-HCl, pH 7.4.  The washed slurry was later incubated for 3 h 
at room temperature with 300 µl of buffer A containing 2.44 × 10-7 M of the [3H]-E2 working 
solution.  Upon completion, the washing step was repeated and 4 ml of scintillation cocktail was 
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added to the slurry.  The mixtures were transferred into scintillation vials and later counted using 
a liquid scintillation counter. 
 
 
 
Figure 6.1: Diagrammatic representation of an amylose resin assay to determine if hERLBD 
can capture estrogen from solution while immobilized on a solid matrix.  Radiolebelled estradiol 
was used to detect binding to the hERLBD of the fusion protein. 
 
6.2.3 Membrane coating assay 
 
Prior to immobilization of the adsorbates (i.e. MBP-hERLBD and MBP) onto the 2% amylose 
functionalized CA membranes, the membranes were shaped such that the external surfaces were 
1 × 1 cm2 in diameter.  The membranes were washed overnight in sterile, deionised water, 
followed by three further washes.  This was followed by the overnight incubation of the 
membranes at 4°C in a buffer (10 mM Tris pH 7.6, 0.15 M NaCl and 0.02% thiomersal) 
containing the adsorbates (0.1 mg/ml final concentration).  The overnight solution was discarded 
and the membrane incubated with rabbit anti-MBP-hERLBD antibody for 2 h at 4°C.  The 
membranes were washed with PBST buffer followed by incubation with donkey anti-rabbit 
antibody for 2 h at 4°C.  After the final wash step, the membranes were subjected to a 
chemilluminescent detection method using the ECL Western Blotting Detection solutions 
(Amersham Biosciences) and resulting signals were analyzed by Hyper film ECL. 
 
6.2.4 Ligand binding capacity 
 
To investigate on the binding capacity of the bioligand to the amylose functionalized membrane, 
washed membrane (1 × 1cm2 in size) were incubated with buffer A containing the adsorbates to 
a final concentration of 0.1 mg/ml.  The resulting membranes were incubated at 4°C for 3 h with 
Stellenbosch University http://scholar.sun.ac.za
 77 
samples collected very 30 min for Pierce protein determination (Figure 6.5). 
 
6.2.5 Ligand recovery and characterization 
 
To further characterize the binding of the affinity ligand to the composite amylose functionalized 
membrane, washed membranes (1 × 1 cm2 in diameter) were incubated overnight at 4°C in 
buffer A (20 mM Tris-HCl pH 7.4, 0.1 M NaCl and 0.1 mM EDTA) containing the affinity 
ligands to a final concentration of 0.1 mg/ml.  Subsequent to the incubation procedure, the 
solution was discarded and the membranes washed four times in chilled 50 mM Tris-HCl, pH 
7.4.  The resulting membranes were transferred into new vials and incubated for 1 h in 1 ml of 
buffer A to which a final concentration of 10 mM maltose was added.  The resulting supernatant 
were analysed with SDS-PAGE and Western blot. 
 
6.2.6 Membrane/E2 binding assay 
 
The MBP-hERLBD immobilized membrane/ E2 binding assay was performed following the 
same general procedure used in the amylose E2 binding assay described above.  E2 binding was 
measured by incubating the MBP-hERLBD coated membrane with 1 ml of buffer A containing 
2.44 × 10-7 M of the [3H]-estradiol working solution (prepared as mentioned above) for 3 h at 
room temperature.  After incubation, the washing step was repeated and the washed membranes 
transferred in to scintillation vials containing 4 ml of the scintillation cocktail.  Counting was 
done using a liquid scintillation counter. 
 
6.3 RESULTS AND DISCUSSION 
 
To assess the binding of the purified MBP-hERLBD to the amylose resin and to test if the 
purified hERLBD could capture estrogen while immobilized on a matrix, radio-labelled E2 was 
used due to its affinity for LBD.  MBP and BSA were included as controls in the binding assay.   
From the results obtained, the percentage of radioactivity remaining after incubation of the E2 
with the functionalized membranes gives an indication that the purified affinity ligand, MBP-
hERLBD, could capture estrogen while immobilized onto the amylose resin.  However, MBP 
and BSA on the other hand showed little or no binding confirming that they both lack binding 
sites for either the resin or E2 or both.  The results shows that an active form of LBD will 
successfully capture estrogens or estrogenic compounds while immobilizes onto a solid support.  
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Figure 6.2: Graph illustrating a radioactive assay performed using amylose resin.  This was to 
determine if MBP-hERLBD fusion protein can capture estrogen from solution.  The results are 
given as percentage of radioactivity remaining, represented as count per minute (CPM) on the 
resin. 
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Figure 6.3: Diagrammatic representation of an immunoblot assay of MBP/MBP-hERLBD, 
MBP.  BSA and Lysozyme detected using the chemiluminescent approach with anti MBP-
hERLBD and donkey anti-rabbit as primary and secondary antibodies respectively. 
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To characterize the membranes for protein immobilization, 0.1 mg/ml of the proteins (MBP and 
MBP-hERLBD fusion protein) were incubated with 1 cm2 of the amylose functionalized 
membrane.  The protein immobilized membranes were subsequently used for Western blot 
analysis (Figure 6.3).  Though it was evident that the degree of binding of the proteins to the 
functionalized membrane was different for each protein used, it was difficult to draw a precise 
conclusion based on the results obtained from the Western blot analysis.  In this regard, digital 
quantification of the black spots present on each 1 cm2 membrane was carried out and the 
obtained results plotted on a bar chat (Figure 6.4).  From the result obtained, MBP and MBP-
hERLBD showed greater binding compared to BSA and Lysozyme used. 
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Figure 6.4: Diagram representing the digital quantification of the black spots present on each 1 
cm2 membrane of the above western blot analysis (Figure 6.3). 
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Figure 6.5: Graphical representation of the degree of binding of MBP, MBP-hERLBD, BSA 
and lysozyme onto the amylose functionalized membrane over time.  The proteins concentration 
prior to the addition of the membranes was 0.1mg/ml. 
 
MBP and MBP-hERLBD binding assay was performed to assess the affinity of the bio-affinity 
ligands to amylose present in the membrane (Figure 6.5).  This result indicates that both affinity 
ligands had an affinity for amylose though as depicted by the result MBP had a greater affinity 
than MBP-hERLBD.  This could be as a result of the fused hERLBD creating steric hindrance 
on the MBP fusion protein thus affecting the binding activity of this molecule.  BSA and 
Lysozyme were included in the assay as negative controls.  Comparing the binding of the 
proteins to the modified membrane, it can be agreed that the affinity functionalized membrane 
was not specific for MBP and MBP-hERLBD binding only, since the BSA and Lysozyme 
bound to the membrane even though it did so partially.  The latter result may be attributed to the 
fact that the membrane offers binding sites for BSA and Lysozyme or some degree of 
hydrophobicity causing the BSA and Lysozyme to adhere to the membrane. 
 
To further verify the immobilization of the protein onto the functionalized membrane a 
desorption assay was performed.  In this experiment the membranes containing the immobilized 
proteins were incubated with a solution containing maltose (final concentration of 10 mM).  
After the incubation of the immobilized membranes with maltose, the solution obtained was 
characterized using Western blot analysis.  As controls, water and another sugar moiety (10 mM 
Sucrose) were used.  This was done to verify if the MBP and MBP-hERLBD could be 
displaced from the membrane using maltose through competitive binding (maltose has a greater 
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affinity for amylose than MBP and MBP-hERLBD fusion protein).  From the Western blot 
results obtained, it was evident that both sugar moieties used could displace the proteins from the 
membrane while a sugar free solution ( Milli-Q® water ) were unable to do this. 
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Figure 6.6: Western blot performed with the supernatant collected after desorption of MBP/ 
MBP-hERLBD fusion proteins from the amylose functionalized membrane.  Desorption was 
done using maltose and sucrose to a final concentration of 10mM.  Lanes 2, 3 and 8, 9 of A 
represent the maltose fractions while lanes 4, 5 and 6, 7 the sucrose fractions.  Lanes 2, 3 and 4 
of B represents an assay performed with the supernatant after the immobilized membrane was 
washed with Milli-Q® water.  Lanes 1 and 10 of A and 1 and 5 of B represent the molecular mass 
markers. 
 
Maltose and sucrose are both disaccharides consisting of two simple sugars: maltose (glucose 
1-4 glucose) and sucrose (glucose 1-4 fructose) with the only difference between these two 
sugars being the ring structure of one of the monomer unit.  In terms of chemical composition, 
these two sugars are very much alike and the two disaccharides can therefore share a common 
binding site on MBP. 
 
The above characterization confirms that the MBP fusion protein and the recombinant protein 
(MBP-hERLBD) were successfully immobilized on the amylose functionalized membrane.  
After the verification, the immobilized membrane was used as a solid affinity matrix for the 
selective recovery of labelled E2 from solution. 
   
A B 
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Considering the interaction existing between the hERLBD and the endogenous estrogen 
hormone, it was expected that an analog of estrogen, such as E2, will bind to an active 
hERLBD.  This binding was, however, not observed in this study as depicted by the above E2 
binding results (Tables 6.1-6.4). 
 
Table 6.1 bolow represent an assay performed using different proteins coated membranes 
incubated with labelled E2 for 1 h.  From the results it was observed that there was no significant 
difference in the percentage binding of E2 existing between the different protein-coated 
membranes.  The percentage binding show that all the membranes bound E2 to the same extent 
irrespective of whether the ligand was immobilized onto the membranes.  Another approach was 
subsequently introduced considering that the above results observed could have been as a result 
of the hydrophobicity of the functionalized membrane (Table 6.2).  Herein, prior to the 
immobilization of the different proteins to the flat sheet membrane, the membranes were 
hydrophilized with 0.1 M NaOH pH 10 for 24 h.  This was to render the membrane less 
hydrophobic.  The E2 binding assay was repeated with the hydrophilized protein-coated 
membranes.  The results obtained from the assay were similar to the results observed when the 
membranes were unhydrophilized.  
 
To further verify the affinity binding of E2 to the hERLBD present on the membrane, the above 
experiments were repeated with the incubation time of the membrane in E2 solution increased to 
3 h (Tables 6.3 and 6.4).  There was no significant change observed in the percentage binding of 
E2 to the hydrophilized membranes.  The only conclusion that could be drawn from the above 
results was that the E2 binding to the membrane increased as the incubation time was increased.  
Also, the binding of E2 to the membrane was not specific. 
 
Several attempts to bind E2 to the amylose functionalized protein coated membrane specifically 
were unsuccessful.  Several factors may have attributed to this failure.  Firstly, it may be that the 
activity of the recombinant protein could be affected by potential interaction between MBP and 
the amylose present in the flat-sheet membrane [15].  The binding of the recombinant protein to 
the membrane may have caused a conformational change within the hERLBD thus affecting the 
affinity of the hERLBD for the E2.  Another factor that could have contributed to the above 
shortcoming may be the orientation of the affinity ligand on the membrane.  The recombinant 
protein may have been incorporated into the membrane in such a way that the affinity site of the 
hERLBD is not properly exposed for E2 binding. 
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Other contributing factors, such as the uneven distribution of the amylose within the membrane, 
the lower surface to bed volume ratio, steric hindrance affecting the affinity ligand, uneven 
membrane thickness as well as the flow distribution can also explain the inability of the 
membrane immobilized MBP- hERLBD to bind E2 [16-18].  The results of E2 binding obtained 
from this bio-assay are represented in Tables 6.1-6.4 below as percentage binding of E2 onto the 
membrane. 
 
Table 6.1: Percentage binding of E2 on an unhydrophilized protein coated membranes.  The E2 
binding assay was carried out at room temperature for 1 h 
 
Membrane  
Type 
Membrane CPM Total 
Supernatant 
CPM 
Total CPM Used % Binding of  
E2 on membrane 
Uncoated 
membrane 
1510 2451 3960 38.1 
MBP-hERLBD 
coated membrane 
1559 2276 3835 40.7 
MBP coated 
membrane 
1899 1879 3779 50.3 
Lysozyme coated 
membrane 
1653 2119 3772 43.8 
BSA coated 
membrane 
1657 2194 3851 43.0 
 
 
 
Table 6.2: Percentage binding of E2 on a 24 h hydrophilized protein coated membranes.  
Hydropilization was done using 0.1 M NaOH pH 10.  The E2 binding assay was carried out at 
room temperature for 1 h 
 
Membrane  
Type 
Membrane CPM Total 
Supernatant 
CPM 
Total CPM Used % Binding of  
E2 on membrane 
Uncoated 
membrane 
1549 2179 3728 41.6 
MBP-hERLBD 
coated membrane 
1551 2154 3705 41.9 
MBP coated 
membrane 
2010 1942 3951 50.9 
Lysozyme coated 
membrane 
1657 2173 3831 43.3 
BSA coated 
membrane 
1488 2269 3757 39.6 
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Table 6.3: Percentage binding of E2 on an unhydrophilized protein coated membrane.  The E2 
binding assay was carried out at room temperature for 3 h 
 
 
Membrane  
Type 
Membrane CPM Total 
Supernatant 
CPM 
Total CPM Used % Binding of  
E2 on membrane 
Uncoated 
membrane 
2570 1372 3942 65.2 
MBP-hERLBD 
coated membrane 
2384 1453 3836 62.1 
MBP coated 
membrane 
2516 1477 3994 63.0 
Lysozyme coated 
membrane 
935 624 1559 60.0 
BSA coated 
membrane 
864 548 1412 61.2 
 
 
Table 6.4: Percentage binding of E2 on a 24 h hydrophilized protein coated membranes.  
Hydropilization was done using 0.1 M NaOH pH 10.  The E2 binding assay was carried out at 
room temperature for 3 h 
 
Membrane  
Type 
Membrane CPM Total 
Supernatant 
CPM 
Total CPM Used % Binding of  
E2 on membrane 
Uncoated 
membrane 
2377 1125 3502 67.9 
MBP-hERLBD 
coated membrane 
2269 1623 3892 58.3 
MBP coated 
membrane 
2667 1356 4024 66.3 
Lysozyme coated 
membrane 
2733 1350 4083 66.9 
BSA coated 
membrane 
2418 1493 3911 61.8 
 
 
 
From Section 6.3, Figure 6.5, approximately 0.063mg of the recombinant protein was 
successfully bound to a 1 cm2 membrane.  This implies that a final concentration of 
approximately 1nmol of the MBP-hERLBD was present on the 1 cm2 membrane given the 
molecular mass of the recombinant protein (66KDa) as depicted in Figure 3.6.  Theoretically, 
one molecule of LBD can only bind one molecule of E2, therefore with 1nmol LBD present on 
the 1 cm2 membrane, an equal amount of E2 (1nmol) can bind to the binding sites of the 
recombinant protein.  Relating the aforementioned result in terms of CPM, a total of 30000CPM 
and cold E2, to a final concentration of 10nmol was used in the binding assay.  Therefore the 
coated membrane was expected to have approximately 3000CPM.  However, this was not the 
case as both the uncoated and coated membranes bound equal quantities of radio-activity (2000 
CPM), indicating none-specific binding of the E2 onto the membrane. It was expected that if the 
recombinant protein was probably immobilized onto the 1 cm2 membrane, exposing its binding 
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sites to freely bind E2, there should have been a significant difference in the binding of the E2 by 
the LBD irrespective of the nature of the membrane. 
 
6.4 CONCLUSIONS 
 
The results obtained from the work described in this chapter have clearly shown that the 
recombinant protein and the MBP fusion proteins have been immobilized onto the amylose 
functionalized membrane.  All attempts, however, to utilize the protein coated membrane for the 
selective binding of E2 were unsuccessful.  This result can be attributed to the fact that, the LBD 
was incorporated into the 1 cm2 membrane in such a manner that the binding sites of the affinity 
ligand wan not well exposed to bind E2.   
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CHAPTER 7 
SUMMARY AND RECOMMENDATIOMS  
 
7.1 SUMMARY 
 
The constant release of endocrine disrupting compounds (EDCs) into water has led to the 
development of several techniques for their detection and recovery.  Among them, affinity 
techniques have proven to be most effective.  In this study, a novel affinity CA modified 
membrane was fabricated based on the interaction occurring between the membrane matrix and 
its immobilized ligands.  The novel membrane was applied as a detection system for the 
recovery of EDCs from environmental water through affinity coupling.  
 
A basic membrane fabrication technique (immersion precipitation) was successfully 
implemented in the fabrication of the affinity CA/amylose functionalized membrane.  The 
membrane surface roughness and surface chemical functional groups were characterized 
successfully, using SEM and FT-IR, respectively.  The results from the SEM and FT-IR were 
used to gain information regarding amylose availability in the membrane.  Changes were 
depicted from the membrane appearance, structure and composition as the concentration of 
amylose in the CA membrane was gradually being inceased.  
 
 Once the membrane was constructed, human estrogen alpha ligand binding domain (hERLBD) 
affinity ligand was immobilized onto the CA/amylose functionalized affinity membrane to create 
appropriate binding sites for EDCs.  With the CA/amylose functionalized membrane lacking in 
hERLBD binding sites, hERLBD was successfully expressed as a fusion protein to maltose 
binding protein (MBP) using E. coli TB1 cells as the host system.  Purification of the 
recombinant protein (MBP-hERLBD) was achieved by using an affinity chromatography 
column with amylose as the affinity matrix.  The purification results were confirmed by 
immunoblot analysis using commercial monoclonal rat anti-hERLBD antibodies.  They were 
also confirmed by using rabbit anti-MBP-hERLBD polyclonal antibodies, generated by 
immunizing a rabbit with MBP-hERLBD acid-treated naked bacteria conjugates.  The resulting 
polyclonal anti-MBP-hERLBD antibodies, as shown by the western blot analyses, did 
recognize both MBP-hERLBD and MBP. 
 
Applying the basic principles of column affinity chromatography, the activity of the ligand 
binding domain (LBD) of the recombinant protein, as well as the interaction between the 
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recombinant protein and the amylose, was investigated.  The binding assay proved to be very 
successful since the recombinant protein could successfully bind E2 while immobilized onto an 
amylose support present in a chromatographic column.  According to the above assay, if amylose 
is successfully incorporated into the membrane matrix in its correct orientation and 
concentration, there is a high probability that it will successfully bind the recombinant ligand. 
 
Basic techniques such as the western blot assay, E2 binding assay and a desorbtion assay, were 
successfully applied in the characterization of the immobilized proteins on the membrane.  The 
results of this study showed that when incubated with the affinity membrane, the MBP-
hERLBD will successfully bind the amylose in the membrane.  It was also observed (using the 
desorption assay) that a solution containing maltose and sucrose will successfully displace the 
proteins adsorbed on the membrane, giving an indication of ligand immobilization. 
 
Once the composite affinity membrane was modified successfully, the membrane was applied as 
an affinity matrix for E2 recovery.  Several attempts to get the affinity ligand (LBD) to bind E2 
specifically in solution were unsuccessful.  The results obtained may be attributable to a number 
of factors, including: 
 
• uneven distribution of the amylose within the membrane; 
• hydrophobic nature of the membrane matrix; 
• the lower surface to bed volume ratio; 
• steric hindrance affecting the affinity ligand; 
• uneven membrane thickness; and 
• flow distribution within membrane. 
 
Resolving the above parameters is a good starting point in solving the abovementioned problems 
encountered by the affinity membrane. 
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7.2 RECOMMENDATIONS 
 
MBP-hERLBD expression and membrane technology are separate fields of study and therefore 
present a plethora of opportunities for future research work.  Following the shortcomings of the 
membrane system used in this study, the following areas should receive further attention. 
 
7.2.1 The membrane matrix 
 
The following parameters should be taken into consideration when developing the membrane 
matrix: 
• more compatible solution(s) should be used in dissolving the polymers to prevent 
demixing of the polymers; 
• changing the orientation of amylose in the membrane to offer better binding to the 
affinity ligand.  This can be achieve by using different casting techniques for the 
membrane production; and  
• with the membrane matrix binding more of the E2 than it should have, using other 
polymeric materials as the matrix support of lower hydrophobicity or reducing the 
hydrophobic nature of the already formed CA membrane. 
 
7.2.2 Membrane affinity ligand 
 
Another point of interest that should be taken into consideration is the adsorption of the affinity 
ligand to the membrane; 
• The affinity ligand should be modified in such a way to minimize steric hindrance 
as much as possible. 
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APPENDIX 
 
The molecular organization and molecular dynamics of polymeric materials are analyzed using 
the combination of techniques.  The FT-IR has been used successfully to characterize the 
structural changes occurring during the fabrication of composite polymeric membranes.  Figures 
A1 to A8 depicts FT-IR diagrams of amylose powder, CA powder, a CA membrane surface, a 
CA membrane, a CA/10% amylose membrane, a CA/15% amylose membrane, a CA/10% 
amylose membrane surface and a CA/15% amylose membrane surface respectively. 
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Figure A1: FT-IR spectrum of amylose powder. 
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Figure A2: FT-IR spectrum of CA powder. 
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Figure A3: FT-IR spectrum of CA membrane surface. 
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Figure A4: FT-IR spectrum of CA membrane. 
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Figure A5: FT-IR spectrum of CA/10% amylose membrane. 
 
 
Stellenbosch University http://scholar.sun.ac.za
 94 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 450.0
27.2
30
35
40
45
50
55
60
65
70
75
80
85
90
92.1
cm-1
%T 
Amylose ++ CA Zantater3977.53
3886.54
3853.93
3836.50
3800.37
3778.11
3731.17
3472.97
2943.24
2887.59
2743.19
2366.54
2347.49
2122.78
1941.91
1747.27
1647.81
1537.90
1515.78
1432.99
1370.83
1231.88
1160.21
1059.17
902.36
802.15
781.54
689.91
602.13
568.41
529.49
476.66
 
Figure A6: FT-IR spectrum of CA/15% amylose membrane. 
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Figure A7: FT-IR spectrum of CA/10%amylose membrane surface. 
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Figure A8: FT-IR spectrum of CA/15% amylose membrane surface. 
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Figure A9: FT-IR spectra Comparing CA and amylose powders, CA/amylose membrane surface, 
CA membrane surface, CA/amylose membrane and CA membrane. 
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